Trump New York fraud bond cut to $175 million in appeal from $454 million
- Trump New York fraud bond cut to $175 million in appeal from $454 million
- 03/25/2024
|
Why Agilent Technologies (A) is a Top Stock for the Long-Term
- The Zacks Focus List offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.
- 03/06/2024
|
Agilent Technologies, Inc. (A) Presents at 44th Annual TD Cowen Health Care Conference (Transcript)
- Agilent Technologies, Inc. (NYSE:A ) 44th Annual TD Cowen Health Care Conference March 4, 2024 2:50 PM ET Company Participants Robert McMahon - SVP and CFO Conference Call Participants Daniel Brennan - TD Cowen Daniel Brennan Great. Here to kick off the Agilent session.
- 03/04/2024
|
Agilent (A) Q1 Earnings & Revenues Beat Estimates, Dip Y/Y
- Agilent's (A) first-quarter fiscal 2024 results reflect softness across the LSAG and DGG segments. Weak momentum in China has been concerning.
- 02/28/2024
|
Agilent Technologies Stock Jumps As Earnings Top Estimates—Key Levels to Watch
- Shares in Agilent Technologies (A) gained nearly 5% in Tuesday's extended-hours trading session after the laboratory supplies maker topped analysts' quarterly top- and bottom-line expectations, despite sales contracting from the prior year.
- 02/27/2024
|
Agilent Technologies, Inc. (A) Q1 2024 Earnings Call Transcript
- Agilent Technologies, Inc. (A) Q1 2024 Earnings Call Transcript
- 02/27/2024
|
Agilent (A) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
- The headline numbers for Agilent (A) give insight into how the company performed in the quarter ended January 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
- 02/27/2024
|
Agilent Technologies (A) Beats Q1 Earnings and Revenue Estimates
- Agilent Technologies (A) came out with quarterly earnings of $1.29 per share, beating the Zacks Consensus Estimate of $1.21 per share. This compares to earnings of $1.37 per share a year ago.
- 02/27/2024
|
3 Top-Rated Stocks to Consider as Earnings Approach
- With representation from a variety of sectors, several top-rated Zacks stocks look attractive ahead of their quarterly reports on Tuesday, February 27.
- 02/26/2024
|
Agilent Technologies (A) to Post Q1 Earnings: What's in Store?
- Agilent's (A) results for the fiscal first quarter are expected to reflect strength across ACG amid weakness in the LSAG and DGG segments.
- 02/26/2024
|
Remitly Global, Inc. (RELY) Q4 2023 Earnings Call Transcript
- Remitly Global, Inc. (RELY) Q4 2023 Earnings Call Transcript
- 02/24/2024
|
Agilent (A) Q1 Earnings Preview: What You Should Know Beyond the Headline Estimates
- Beyond analysts' top -and-bottom-line estimates for Agilent (A), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended January 2024.
- 02/22/2024
|
Agilent Technologies (A) Surpasses Market Returns: Some Facts Worth Knowing
- Agilent Technologies (A) reachead $132.24 at the closing of the latest trading day, reflecting a +1.91% change compared to its last close.
- 02/14/2024
|
Agilent Technologies (A) Outperforms Broader Market: What You Need to Know
- In the most recent trading session, Agilent Technologies (A) closed at $134.07, indicating a +0.96% shift from the previous trading day.
- 02/08/2024
|
Agilent Technologies (A) Stock Slides as Market Rises: Facts to Know Before You Trade
- Agilent Technologies (A) concluded the recent trading session at $132.97, signifying a -0.06% move from its prior day's close.
- 02/02/2024
|
FTV vs. A: Which Stock Is the Better Value Option?
- Investors with an interest in Electronics - Testing Equipment stocks have likely encountered both Fortive (FTV) and Agilent Technologies (A). But which of these two stocks presents investors with the better value opportunity right now?
- 02/01/2024
|
Agilent Technologies (A) Advances While Market Declines: Some Information for Investors
- In the latest trading session, Agilent Technologies (A) closed at $130.99, marking a +0.85% move from the previous day.
- 01/26/2024
|
Agilent to Announce First-Quarter Fiscal Year 2024 Financial Results Feb. 27
- SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) will release financial results for the first quarter of fiscal year 2024 after the stock market closes on Tuesday, Feb. 27. In addition, the company will host a conference call to discuss the results at 1:30 p.m. PST. To join the listen-only conference call webcast, click the link on the Events section of Agilent's investor relations website. A recording of the call will also be available on the website for 90 days. About.
- 01/25/2024
|
The 3 Most Promising Picks in Manufacturing Stocks for 2024
- Over the past 80 years, the United States faced a persistent issue of in-state manufacturing decline, marked by a shift towards research and development rather than domestic production. The trend led to a significant loss of manufacturing jobs, peaking in the 2000s with a 33% decrease.
- 01/22/2024
|
Agilent (A) Boosts DGG Segment With ProteoAnalyzer System
- Agilent (A) bolsters protein analysis capabilities with the ProteoAnalyzer system.
- 01/17/2024
|
FTV vs. A: Which Stock Should Value Investors Buy Now?
- Investors looking for stocks in the Electronics - Testing Equipment sector might want to consider either Fortive (FTV) or Agilent Technologies (A). But which of these two companies is the best option for those looking for undervalued stocks?
- 01/16/2024
|
U.S. Wide-Moat Stocks On Sale - The January 2024 Heat Map
- Our 3-step process focuses on wide-moat stocks (as per Morningstar's rating).
- 01/10/2024
|
Agilent Technologies, Inc. (A) Presents at J.P. Morgan 42nd Annual Healthcare Conference Transcript
- Agilent Technologies, Inc. (A) Presents at J.P. Morgan 42nd Annual Healthcare Conference Transcript
- 01/09/2024
|
How I Beat The Market Again In 2023
- I express frustration with the constant negativity surrounding the idea that beating the market is impossible for the average investor. I share my personal success in beating the market in 2023, with a time-weighted return of 28.02%. I emphasize the importance of buying high-quality companies at fair prices and holding them for the long term, while also highlighting the power of compounding dividends.
- 01/05/2024
|
Agilent Technologies Hit A Homerun
- Agilent Technologies' Q4 revenue was $1.69 billion, reflecting a 9.7% YoY decline, but the company achieved a healthy operating margin of 27.8%. Most regions showed sequential growth except for China, which saw a 31% decline. Agilent anticipates a slow but steady recovery in fiscal year 2024 with cost-saving measures and expects revenue in the range of $6.71 to $6.81 billion.
- 12/23/2023
|
Why Is Agilent (A) Up 12.8% Since Last Earnings Report?
- Agilent (A) reported earnings 30 days ago. What's next for the stock?
- 12/20/2023
|
Agilent to Present at the 42nd Annual J.P. Morgan Healthcare Conference
- SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that CEO Mike McMullen and CFO Bob McMahon will present at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco on Tuesday, Jan. 9, 2024, at 9:45 a.m. Pacific Time. A live audio webcast and replay of the presentation will be available on the Agilent Investor Relations website. About Agilent Technologies Agilent Technologies Inc. (NYSE: A) is a global leader in analytical and clinical laborato.
- 12/18/2023
|
Agilent Technologies, Inc. (A) Evercore ISI HealthCONx Conference 2023 Transcript
- Agilent Technologies, Inc. (NYSE:A ) Evercore ISI HealthCONx Conference 2023 November 29, 2023 10:50 AM ET Company Participants Mike McMullen - President and Chief Executive Officer Bob McMahon - Chief Financial Officer Conference Call Participants Vijay Kumar - Evercore ISI Vijay Kumar Thanks everyone for joining us this morning. I'm Vijay Kumar.
- 11/29/2023
|
Why I Made Big Changes To My Dividend Growth Portfolio
- I've made significant changes to my portfolio due to buying a new house and selling stocks from my portfolio to raise cash. My goal is to prioritize building a passive income stream, but I recognize the value of investing in a new home for improved quality of life. In this article, I discuss different options to pay for the new home, including taking out a mortgage or selling more stock if mortgage rates remain high.
- 11/29/2023
|
Earn A Potential 10% Plus Income With Options (December 2023)
- We explain why selling cash-covered puts and covered calls are relatively safe choices for earning a high income. We will discuss how to formulate a sustainable and repeatable options income strategy. In this monthly series, we present how to go about selecting the right kind of stocks for options income. We present two lists of 10 stocks with multiple scenarios: PUT options, CALL options, and deep-in-the-money CALL options.
- 11/27/2023
|
Down 24% This Year Will Agilent Technologies Stock Rebound To Its Pre-Inflation High Of $175?
- The company's top line has contracted in the recent past due to lower sales in China.
- 11/22/2023
|
Agilent (A) Q4 Earnings & Revenues Beat Estimates, Down Y/Y
- Agilent's (A) fourth-quarter fiscal 2023 results are hurt by weakness in the LSAG segment and softness in the China market.
- 11/21/2023
|
Agilent (A) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
- Although the revenue and EPS for Agilent (A) give a sense of how its business performed in the quarter ended October 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
- 11/20/2023
|
Agilent Technologies, Inc. (A) Q4 2023 Earnings Call Transcript
- Agilent Technologies, Inc. (NYSE:A ) Q4 2023 Earnings Conference Call November 20, 2023 4:30 PM ET Company Participants Parmeet Ahuja - IR Mike McMullen - President and CEO Robert McMahon - SVP and CFO Sam Raha - President, Agilent Diagnostics & Genomics Group Padraig McDonnell - President, Agilent CrossLab Group Phil Binns - President of the Agilent Life Sciences and Applied Markets Group Conference Call Participants Vijay Kumar - Evercore ISI Patrick Donnelly - Citigroup Inc. Matt Sykes - Goldman Sachs Rachel Vatnsdal - JPMorgan Derik De Bruin - Bank of America Jack Meehan - Nephron Research Puneet Souda - Leerink Partners Josh Waldman - Cleveland Research Daniel Brennan - TD Cowen Dan Leonard - UBS Operator Ladies and gentlemen, welcome to the Agilent Technologies Q4 2023 Earnings Conference Call. My name is Bo and I will be coordinating your call today.
- 11/20/2023
|
Agilent Technologies stock higher as 4Q results beat estimates
- Agilent Technologies (NYSE:A) Inc after Monday's close announced fourth quarter 2023 financial results that exceeded expectations on both the top and bottom lines. The analytical and clinical laboratory technologies provider's adjusted earnings per share (EPS) for the period declined 10% year over year to $1.38, while its revenue fell 9% to $1.69 billion.
- 11/20/2023
|
3 Biotech Stocks With Big-Time Breakthrough Potential
- In a world in constant evolution and growth, more and more companies are needed that are committed to development and research in the health area. These biotech companies are not only doing the job, but also have potential for future growth.
- 11/20/2023
|
Earnings Exchange: Medtronic, Agilent Technologies & Trip.com
- Ari Wald, managing director and head of technical analysis at Oppenheimer, joins 'The Exchange' to discuss Medtronic, Agilent Technologies, and Trip.com.
- 11/20/2023
|
Agilent Technologies' overexposure to China headwinds prompts analyst downgrade
- Agilent Technologies (NYSE:A) has been downgraded from ‘Buy' to ‘Neutral' by UBS analysts who believe that the life sciences and diagnostics company's overexposure to regional headwinds in China, instrument demand normalization and softening cyclical spending could pressure forecasts. They highlighted that Agilent makes 20% of its sales in China but a lack of government stimulus, anti-corruption efforts, reshoring, and limited funding availability have pressured biopharma demand in the country.
- 11/17/2023
|
Agilent to Present at the Evercore ISI HealthCONx Conference
- SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that Mike McMullen, president and chief executive officer, and Bob McMahon, chief financial officer, will present at the 6th Annual Evercore ISI HealthCONx conference on Wednesday, Nov. 29, at 10:50 a.m. ET. A live webcast and audio archive of the virtual session will be available in the News and Events section of Agilent's Investor Relations website. About Agilent Technologies Agilent Technologies Inc. (N.
- 11/17/2023
|
What to Note Ahead of Agilent Technologies' (A) Q4 Earnings
- Agilent's (A) results for the fiscal fourth quarter are expected to reflect strength across the ACG amid weakness in the LSAG segment.
- 11/16/2023
|
Agilent Technologies (A) Beats Stock Market Upswing: What Investors Need to Know
- In the closing of the recent trading day, Agilent Technologies (A) stood at $113.60, denoting a +1.78% change from the preceding trading day.
- 11/15/2023
|
Agilent raises dividend by 5%
- Agilent Technologies Inc. A, +1.78% late Wednesday said it has increased its dividend 5% to 23.6 cents a share. The dividend will be paid on Jan. 24 to shareholders of record as of the close of business on Jan. 2, the company said.
- 11/15/2023
|
Agilent Technologies (A) Stock Dips While Market Gains: Key Facts
- Agilent Technologies (A) reachead $109.39 at the closing of the latest trading day, reflecting a -1.04% change compared to its last close.
- 11/08/2023
|
Agilent (A) Bolsters NTD Research With SIDC Partnership
- Agilent (A) collaborates with Sarawak Infectious Disease Centre to provide the latter with its 6475 triple quadrupole LC/MS system, enabling rapid outbreak response for neglected tropical diseases.
- 10/10/2023
|
Agilent Not As Agile As Hoped As Life Sciences Demand Proves To Be Less Than Invincible
- Demand from biopharmas for life sciences equipment has not sustained high expectations in 2023, leading to weaker growth and negative revisions for companies like Agilent. Biopharma and industrial companies have significantly pulled back on spending for tools, and Agilent's above-average leverage to capex makes it more vulnerable. Growth in the services business is encouraging, and I like the ongoing investments in oligonucleotide production capabilities as mRNA and siRNA pipelines continue to grow.
- 09/26/2023
|
Agilent: Dips Into GARP Territory, Shares At A Crucial Spot On The Chart
- The Healthcare sector has seen a modest bid since mid-July compared to the S&P 500, with a reach for perceived safety. Agilent Technologies is a leading supplier in the Life Sciences Tools and Services industry. Agilent's earnings and valuation outlooks are mixed, with weak near-term growth but potential for improvement in the future.
- 09/26/2023
|
Illumina names Agilent executive as new CEO
- Illumina Inc. ILMN, +1.96% on Tuesday announced that its board has appointed Agilent Technologies Inc. A, +0.69% senior vice president Jacob Thaysen as its new CEO, effective Sept. 25. The DNA sequencing company faced leadership turmoil after its proxy fight earlier this year with activist investor Carl Icahn, and CEO Francis deSouza stepped down in June.
- 09/05/2023
|
Agilent (A) Q3 Earnings Beat Estimates, Revenues Fall Y/Y
- Agilent Technologies' (A) third-quarter fiscal 2023 results reflect weakness in the LSAG segment and China market.
- 08/16/2023
|
Agilent stock falls after lab instrument maker trims full-year outlook on China weakness
- Agilent Technologies Inc. A shares fell 2% premarket on Wednesday after the laboratory instrument maker late Tuesday trimmed its full-year revenue and earnings outlook, citing weakness in China. The company now expects full-year revenue in the range of $6.80 to $6.85 billion, down from $6.93 to $7.03 billion previously, and full-year adjusted earnings per share of $5.40 to $5.43, versus a previous forecast of $5.60 to $5.65.
- 08/16/2023
|
Agilent Technologies, Inc. (A) Q3 2023 Earnings Call Transcript
- Agilent Technologies, Inc. (NYSE:A ) Q3 2023 Earnings Conference Call August 15, 2023 4:30 PM ET Company Participants Parmeet Ahuja - IR Mike McMullen - President and CEO Robert McMahon - SVP and CFO Padraig McDonnell - President, Agilent CrossLab Group Sam Raha - President, Agilent Diagnostics & Genomics Group Jacob Thaysen - President, Agilent Life Science & Applied Markets Group Conference Call Participants Matt Sykes - Goldman Sachs Jack Meehan - Nephron Research Vijay Kumar - Evercore ISI Dan Leonard - Credit Suisse Brandon Couillard - Jefferies Puneet Souda - Leerink Partners Rachel Vatnsdal - JPMorgan Patrick Donnelly - Citi Derik De Bruin - Bank of America Josh Waldman - Cleveland Research Dan Brennan - TD Cowen Luke Sergott - Barclays Operator Ladies and gentlemen, welcome to the Agilent Technologies Q3 2023 Earnings Conference Call. My name is Bo and I will be coordinating your call today.
- 08/15/2023
|
Markets Remain Sold; H&R Block (HRB), Agilent (A) Beat
- The Dow slid -360 points in today's trading session, -1.02%, while the Nasdaq was down -157 points, -1.14%.
- 08/15/2023
|
Agilent (A) Reports Q3 Earnings: What Key Metrics Have to Say
- The headline numbers for Agilent (A) give insight into how the company performed in the quarter ended July 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
- 08/15/2023
|
Agilent Technologies cuts annual forecasts on China weakness
- Medical equipment maker Agilent Technologies cut annual profit and sales forecasts for a second straight quarter as demand stays soft in major market China due to a slow economic recovery.
- 08/15/2023
|
The Afterhours: Disney sued for withholding profits; Cava, Agilent and Stride report earnings
- The Walt Disney Company (NYSE:DIS) is being sued by Hollywood financer TSG Entertainment for allegedly withholding millions of dollars worth of film profits. The suit, filed Tuesday in Los Angeles Superior Court, accuses Disney and 20th Century Fox of breaching contract by withholding as much as $40 million in profits and signing side agreements to boost its own streaming platform and share price, according to reports.
- 08/15/2023
|
Agilent Technologies 3Q financial results beat estimates; guidance disappoints
- Agilent Technologies (NYSE:A) Inc announced after Tuesday's close that its third-quarter 2023 revenue slipped 2.7% year over year to $1.67 billion but edged past the consensus estimate of $1.66 billion. The analytical and clinical laboratory technologies provider also recorded better-than-expected earnings per share (EPS) of $1.43, exceeding the consensus forecast by $0.07.
- 08/15/2023
|
Markets Rise at Midday, on Track for a Monthly Gain on Profits, Lower Inflation
- U.S. equities advanced at midday on Monday, July 31, 2023, heading for a winning month on strong earnings and easing inflation.
- 07/31/2023
|
RTX tumbles after disclosing engine manufacturing issue on some A320 planes
- RTX said some 200 engines will have to be removed from airline fleets for accelerated inspections.
- 07/25/2023
|
Agilent to Announce Third-Quarter Fiscal Year 2023 Financial Results Aug. 15
- SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) will release financial results for the third quarter of fiscal year 2023 after the stock market closes on Tuesday, Aug. 15. In addition, the company will host a conference call to discuss the results at 1:30 p.m. PDT. To join the listen-only conference call webcast, click the link on the Events section of Agilent's investor relations website. A recording of the call will also be available on the website for 90 days. About.
- 07/19/2023
|
Agilent Technologies - A Wealth Compounder 30% Below Its Highs
- Agilent Technologies, a $35 billion leader in global life sciences, is trading 30% below its all-time high and 20% down year-to-date, presenting a potential growth/value opportunity. Despite challenges with conversion rates and macro uncertainties, Agilent's focus on resilient areas like pharmaceuticals, aggressive R&D spending, and global presence makes it a compelling investment. The company is benefiting from tailwinds in MedTech, biotechnology, and life science tools, and anticipates a continued increase in recurring revenue or consumables over time.
- 07/13/2023
|
U.S. Wide-Moat Stocks On Sale - The July 2023 Heat Map
- Our 3-step process focuses on wide-moat stocks (as per Morningstar's rating). We are only interested in those targets that are attractively valued in historical comparison. We share the heat map of the most investable candidates that may be worth your time for further analysis.
- 07/06/2023
|
Dividend Champion, Contender, And Challenger Highlights: Week Of June 25
- A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates.
- 06/25/2023
|
Agilent Technologies Stock: Ready to Rise off the Floor
- Agilent Technologies Inc. NYSE: A stock is underperforming the market, trading down 19% year-to-date. Agilent is a leading global provider of laboratory technologies and equipment.
- 06/21/2023
|
Medicals Stocks Waters, Agilent, Illumina Show Growth Potential
- Investors seeking growth often have no choice other than paying up for a stock with strong potential. However, there are some stocks that appear to be trading at low valuations relative to their growth potential.
- 06/20/2023
|
Agilent (A) Boosts LSAG Segment With New GPC/SEC Solutions
- Agilent Technologies (A) expands InfinityLab GPC/SEC portfolio to cater well to the needs of scientists in the macromolecular analysis.
- 06/14/2023
|
Agilent (A) Boosts LCMS Portfolio With New Systems Launch
- Agilent Technologies (A) strengthens its Life Sciences & Applied Markets Group (LSAG) segment with 6495 LC//TQ and Revident LC/Q-TOF.
- 06/07/2023
|
U.S. Wide-Moat Stocks On Sale - The June 2023 Heat Map
- Our 3-step process focuses on wide-moat stocks (as per Morningstar's rating). We are only interested in those targets that are attractively valued in historical comparison. We share the heat map of the most investable candidates that may be worth your time for further analysis.
- 06/06/2023
|
Agilent Technologies Stock: Starting To Look Appealing
- Agilent Technologies, Inc. stock has long traded at a premium valuation. The company has traditionally performed well, thanks to a solid positioning and continued M&A efforts.
- 05/25/2023
|
Goldman Sachs Maintains Agilent Technologies Buy Recommendation
- Fintel reports that on May 24, 2023, Goldman Sachs maintained coverage of Agilent Technologies (NYSE:A) with a Buy recommendation.
- 05/24/2023
|
Agilent (A) Q2 Earnings Match Estimates, Revenues Rise Y/Y
- Agilent Technologies' (A) second-quarter fiscal 2023 results reflect strength across LSAG and ACG segments.
- 05/24/2023
|
Why Agilent Technologies Stock Is Sinking Today
- Agilent topped Wall Street's consensus earnings estimate in its latest quarter. However, market uncertainties caused the company to provide weaker-than-expected guidance.
- 05/24/2023
|
Agilent Technologies stock tumbles after it lowers outlook for its fiscal year
- Agilent Technologies (NYSE:A) Inc stock tumbled after it cut its outlook for its fiscal year 2023 while noting that demand from biotech companies had dried up in the difficult environment. “We expect this constrained capital environment to remain in place throughout the course of our fiscal year.
- 05/24/2023
|
Agilent Gets a Downgrade After Strong Earnings. Here's Why.
- The laboratory instruments maker posted earnings of $1.27 per share, better than the $1.26 expected by analysts.
- 05/24/2023
|
Agilent Technologies, Inc. (A) Q2 2023 Earnings Call Transcript
- Agilent Technologies, Inc. (NYSE:A ) Q2 2023 Earnings Conference Call May 23, 2023 4:30 PM ET Company Participants Parmeet Ahuja - IR Mike McMullen - President and CEO Robert McMahon - SVP and CFO Padraig McDonnell - President, Agilent CrossLab Group Sam Raha - President, Agilent Diagnostics & Genomics Group Jacob Thaysen - President, Agilent Life Science & Applied Markets Group Conference Call Participants Brandon Couillard - Jefferies Vijay Kumar - Evercore ISI Puneet Souda - SVB Securities Matt Sykes - Goldman Sachs Rachel Vatnsdal - JPMorgan Dan Leonard - Credit Suisse Mike Ryskin - Bank of America Dan Brennan - TD Cowen Jack Meehan - Nephron Patrick Donnelly - Citi Josh Waldman - Cleveland Research Liza Garcia - UBS Operator Ladies and gentlemen, welcome to the Agilent Technologies' Q2 2023 Earnings Call. My name is Sarah, and I will be coordinating your call today.
- 05/23/2023
|
Agilent Technologies (A) Meets Q2 Earnings Estimates
- Agilent Technologies (A) came out with quarterly earnings of $1.27 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $1.13 per share a year ago.
- 05/23/2023
|
Agilent shares fall after ‘increased market uncertainties' weigh on outlook
- Shares of Agilent Technologies Inc. A, -0.35% fell after hours on Tuesday after the laboratory-equipment maker cut its full-year outlook to reflect “increased market uncertainties” and issued a weaker-than-expected third-quarter forecast. The company said it expected full-year sales of $6.93 billion to $7.03 billion, compared to a prior forecast of $7.03 billion to $7.1 billion given in February.
- 05/23/2023
|
Agilent to Present at Jefferies and Goldman Sachs Healthcare Conferences
- SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that the company will participate in Q&A sessions at the Jefferies and Goldman Sachs healthcare conferences. Below are details of each session. Jefferies Global Healthcare Conference Mike McMullen, Agilent President and CEO Wednesday, June 7 9:00 – 9:25 a.m. ET / 6:00 – 6:25 a.m. PT Goldman Sachs 44th Annual Global Healthcare Conference Bob McMahon, Agilent CFO Tuesday, June 13 1:00 – 1:40 p.m. ET / 10.
- 05/22/2023
|
Agilent Technologies (A) to Post Q2 Earnings: What's in Store?
- Agilent's (A) results for the fiscal second quarter are expected to reflect strength across the LSAG, ACG and DGG segments.
- 05/19/2023
|
Why Earnings Season Could Be Great for Agilent (A)
- Agilent (A) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
- 05/18/2023
|
These 2 Computer and Technology Stocks Could Beat Earnings: Why They Should Be on Your Radar
- The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
- 05/16/2023
|
Agilent (A) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
- After losing some value lately, a hammer chart pattern has been formed for Agilent (A), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.
- 05/11/2023
|
3 Electronics Stocks With Upbeat Industry Prospects to Watch
- The Zacks Electronics -Testing Equipment industry players, such as A, AME and FTV, are poised well to benefit from the solid demand for Test Systems and 5G prospects.
- 05/04/2023
|
China-Exposed Stocks Have Rallied, but Bargains Still Exist, Says Analyst
- Jefferies analyst Desh Peramunetilleke says cheap stocks set to benefit from China's rebound include Keysight, Qualcomm, Agilent, Danaher, and Corning.
- 05/02/2023
|
Will Agilent (A) Beat Estimates Again in Its Next Earnings Report?
- Agilent (A) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- 05/01/2023
|
Agilent to Announce Second-Quarter Fiscal Year 2023 Financial Results May 23
- SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) will release financial results and hold an earnings conference call for the second quarter of fiscal year 2023 after the stock market closes on Tuesday, May 23 at 1:30 p.m. PDT. To join the listen-only conference call webcast, click the link on the Events section of Agilent's investor relations website. A recording of the call also will be available on the website for 90 days. About Agilent Technologies Agilent Technologi.
- 04/26/2023
|
Agilent (A) Boosts Reach to Biopharma Researchers With PathAI
- Agilent Technologies (A) partners with PathAI to deliver an AI-powered CDx assay development solution.
- 04/13/2023
|
Why Agilent Technologies (A) is a Top Growth Stock for the Long-Term
- Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
- 03/27/2023
|
Earn Double-Digit Income With Options (April 2023)
- We explain why selling cash-covered puts and covered calls are relatively safe choices for earning a high income. We will discuss how to formulate an options income strategy that's sustainable and repeatable.
- 03/27/2023
|
Dividend Champion, Contender, And Challenger Highlights: Week Of March 26
- A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends.
- 03/25/2023
|
Agilent (A) Boosts Digital Pathology Reach With Hamamatsu Deal
- Agilent Technologies (A) signs a digital pathology solutions distribution agreement with Hamamatsu in a bid to strengthen its DGG segment.
- 03/14/2023
|
Agilent (A) Boosts Biopharma Solutions Offerings With e-Msion
- Agilent Technologies (A) announces the acquisition of e-Msion, to bolster its Life Sciences & Applied Markets Group segment.
- 03/13/2023
|
Agilent (A) to Boost Digital Pathology Reach With Proscia Deal
- Agilent Technologies (A) signs a multi-year distribution agreement with Proscia in a bid to strengthen its DGG segment.
- 03/10/2023
|
If Howard Marks' Sea Change Memo Is Correct, REITs And High Yield Stocks Look Unattractive
- Yesterday, Chairman Powell signaled more rate hikes are required to tame this stubborn spell of inflation. The entire yield curve has moved up, and notably, during FY 2023. On December 13, 2022, Howard Marks penned a compelling piece - Sea Change. His chief argument is the era of cheap money was the driver of the robust equity returns.
- 03/08/2023
|
Agilent to Present at Barclays Global Healthcare Conference
- SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that Chief Financial Officer Bob McMahon will participate in a Q&A session at the Barclays Global Healthcare Conference in Miami Beach, Florida, on March 15 at 3:05 p.m. EST. Participants can join the webcast by accessing the link from the Agilent Investor Relations website. A replay of the session will also be available for 90 days after the event. About Agilent Technologies Agilent Technologies Inc.
- 03/06/2023
|
3 Reasons Growth Investors Will Love Agilent (A)
- Agilent (A) possesses solid growth attributes, which could help it handily outperform the market.
- 03/03/2023
|
Agilent (A) Loses -11.54% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
- The heavy selling pressure might have exhausted for Agilent (A) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
- 03/02/2023
|
Agilent Technologies (A) Surpasses Q1 Earnings and Revenue Estimates
- Agilent (A) delivered earnings and revenue surprises of 4.58% and 3.78%, respectively, for the quarter ended January 2023. Do the numbers hold clues to what lies ahead for the stock?
- 02/28/2023
|
Earn Double-Digit Income With Options (March 2023)
- We explain why selling cash-covered puts and covered calls are relatively safe choices for earning a high income. We will discuss how to formulate an options income strategy that's sustainable and repeatable.
- 02/28/2023
|
Agilent Technologies (A) to Post Q1 Earnings: What's in Store?
- Agilent Technologies (A) first-quarter fiscal 2023 results are likely to reflect strength in LSAG, ACG and DGG segments.
- 02/27/2023
|
Time to Buy These Innovative Stocks Before Earnings?
- Investors will certainly want to keep Agilent Technologies (A) and Sterling Infrastructure (STRL) on their radars as there could still be plenty of upside and opportunity in these innovative companies.
- 02/24/2023
|
The 3 Most Overlooked Stocks to Buy Now
- The stock market bloodbath is finally starting to subside. And, with inflation finally cooling off, it is time to look for some of the top most overlooked stocks.
- 02/16/2023
|
5 Top Dividend Growth Stocks to Buy in the Month of Love
- Archer-Daniels (ADM), Agilent Technologies (A), Republic Services (RSG), Deere & Company (DE) and Cardinal Health (CAH) seem solid picks for this month.
- 02/01/2023
|
Agilent to Announce First-Quarter Fiscal Year 2023 Financial Results Feb. 28
- SANTA CLARA, Calif.--( BUSINESS WIRE )--Agilent Technologies Inc. (NYSE: A) will release financial results for the first quarter of fiscal year 2023 after the stock market closes on Tuesday, Feb. 28. The company will host a live webcast of its earnings conference call in listen-only mode on the same day. Below are details for the webcast:
- 01/30/2023
|
5 Stocks With Upgraded Broker Ratings for Solid Returns in 2023
- As brokers have a deeper insight into stocks, one must follow rating upgrades for solid returns. We pick Philip Morris (PM), Kroger (KR), Expedia (EXPE), Lyft (LYFT) and Agilent (A) as these witness rating upgrades.
- 01/30/2023
|
These 3 Companies Can't Get Enough of Their Own Stock
- Stock buybacks, also known as share repurchase programs, are a common strategy we see implemented by companies to boost shareholder value. With these companies buying, it raises a valid question: Are shares undervalued?
- 01/26/2023
|
Best Growth Stocks to Buy for January 26th
- A, WTKWY and KNBE made it to the Zacks Rank #1 (Strong Buy) growth stocks list on January 26, 2023.
- 01/26/2023
|
Agilent CEO vows no layoffs in 2023
- In a month marred by job cuts seemingly everywhere in Silicon Valley, Agilent Technologies Inc. A, +2.01% Chief Executive Mike McMullen pledged no layoffs this year in a meeting with employees last week. Shares of Agilent are up 15% over the last 12 months.
- 01/23/2023
|
Dividend Champion, Contender, And Challenger Highlights: Week Of January 22
- A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends.
- 01/22/2023
|
Are Computer and Technology Stocks Lagging Agilent Technologies (A) This Year?
- Here is how Agilent Technologies (A) and Fastly (FSLY) have performed compared to their sector so far this year.
- 01/20/2023
|
Agilent Technologies (A) Is Up 6.26% in One Week: What You Should Know
- Does Agilent Technologies (A) have what it takes to be a top stock pick for momentum investors? Let's find out.
- 01/19/2023
|
These 4 Stocks Boast Impressive Interest Coverage Ratio
- A company capable of generating earnings well above its interest expense can withstand financial hardship. Herc Holdings (HRI), Nexstar Media (NXST), Expedia Group (EXPE) and Agilent Technologies (A) are sound enough to meet financial obligations.
- 01/16/2023
|
Agilent Technologies: A Proven Track Record Of Shareholder Value Creation, Hold
- Agilent Technologies has been successfully refocusing on high-growth areas and this is reflected in its financial results. The company has a strategy to continue this trajectory by targeting 5-7% core growth, expanding operating margins by 50-100 basis points per year, and deploying capital in a balanced manner.
- 01/15/2023
|
Agilent Technologies, Inc. (A) CEO Michael McMullen Presents at 41st Annual J.P. Morgan Healthcare Conference (Transcript)
- Agilent Technologies, Inc. (NYSE:A ) 41st Annual J.P. Morgan Healthcare Conference January 10, 2023 12:00 PM ET Company Participants Michael McMullen - President and CEO Robert McMahon - SVP and CFO Conference Call Participants Rachel Vatnsdal - JP Morgan Rachel Vatnsdal Perfect.
- 01/12/2023
|
5 Top Dividend Growth Stocks for Assured Returns in 2023
- Nexstar Broadcasting (NXST), Walmart (WMT), Booz Allen (BAH), Agilent (A) and Agnico Eagle Mines (AEM) look like solid choices to build the 2023 portfolio.
- 01/12/2023
|
Agilent Technologies, Inc. (A) Goldman Sachs Healthcare CEOs Unscripted Conference Transcript
- Agilent Technologies, Inc. (NYSE:A ) Goldman Sachs Healthcare CEOs Unscripted Conference January 5, 2022 2:05 PM ET Company Participants Mike McMullen – Chief Executive Officer Bob McMahon – Chief Financial Officer Conference Call Participants Matt Sykes – Goldman Sachs Matt Sykes All right. Good afternoon, everyone.
- 01/11/2023
|
Agilent's stock is up on repurchase plan, $725 million investment
- Agilent Technologies Inc.'s stock A, +5.21% is up more than 5% on Tuesday following news the Silicon Valley company unveiled a stock repurchase plan of up to $2 billion and its intention to plow $725 million into its manufacturing capacity. Agilent on Monday said its share repurchase program of common stock, begins March 1.
- 01/10/2023
|
Agilent: Flexing Its Build And Buy Strategy, But Wait For A Pullback
- Agilent shows growth in all its end markets, providing the company with positive core revenue growth. It shows margin expansion and has a positive cash flow outlook from the management.
- 01/10/2023
|
Agilent to spend $2 billion on share repurchases
- Agilent Technologies Inc. A, -0.14% shares rose about 1% in after-hours trading Monday, after the company announced plans for a $2 billion share-repurchase plan. The stock-buyback plan launches March 1, replacing a repurchase program that did not have a set target.
- 01/09/2023
|
Is Agilent Technologies (A) Stock Outpacing Its Computer and Technology Peers This Year?
- Here is how Agilent Technologies (A) and Alps Electric (APELY) have performed compared to their sector so far this year.
- 01/04/2023
|
Investors Heavily Search Agilent Technologies, Inc. (A): Here is What You Need to Know
- Zacks.com users have recently been watching Agilent (A) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
- 12/30/2022
|
Agilent (A) Upgraded to Buy: Here's What You Should Know
- Agilent (A) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
- 12/27/2022
|
25 Upcoming Dividend Increases To Finish 2022
- All stocks have at least five fiscal years of dividend growth history and come from the U.S. Dividend Champions List. They have an average increase of 8% and a median increase of 5.4%.
- 12/22/2022
|
Here is What to Know Beyond Why Agilent Technologies, Inc. (A) is a Trending Stock
- Zacks.com users have recently been watching Agilent (A) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
- 12/19/2022
|
Agilent to Present at Goldman Sachs and J.P. Morgan Healthcare Conferences
- SANTA CLARA, Calif.--( BUSINESS WIRE )--Agilent Technologies Inc. (NYSE: A) today announced that CEO Mike McMullen and CFO Bob McMahon will present at the Goldman Sachs Healthcare CEOs Unscripted Conference and the J.P. Morgan Healthcare Conference. Both conference presentations will be webcast live. Details are included below.
- 12/16/2022
|
Agilent (A) Boosts DGG Offerings With ctDx FIRST Approval
- Agilent Technologies receives FDA approval for its Resolution ctDx FIRST as a companion diagnostic for the identification of advanced non-small cell lung cancer patients with KRAS G12C mutations.
- 12/14/2022
|
5 Top Dividend Growth Stocks to Buy Amid Volatility
- Archer-Daniels-Midland (ADM), Deere & Company (DE), Booz Allen Hamilton (BAH), Agilent Technologies (A), and Boyd Gaming (BYD) could be compelling picks amid volatility.
- 12/09/2022
|
Is Trending Stock Agilent Technologies, Inc. (A) a Buy Now?
- Zacks.com users have recently been watching Agilent (A) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
- 12/06/2022
|
Agilent (A) Q4 Earnings Surpass Estimates, Revenues Rise Y/Y
- Agilent's (A) results for the fiscal fourth quarter reflect strong momentum in the pharma and applied markets. Also, robust demand across all end markets in China remained a positive.
- 11/22/2022
|
Agilent Technologies, Inc. (A) Q4 2022 Earnings Call Transcript
- Agilent Technologies, Inc. (NYSE:A ) Q4 2022 Earnings Conference Call November 21, 2022 4:30 PM ET Company Participants Parmeet Ahuja - Investor Relations Mike McMullen - President and Chief Executive Officer Robert McMahon - Senior Vice President and Chief Financial Officer Jacob Thaysen - President, Agilent Life Science and Applied Markets Group Padraig McDonnell - President, Agilent CrossLab Group Sam Raha - President, Agilent Diagnostics and Genomics Group Conference Call Participants Vijay Kumar - Evercore ISI Matt Sykes - Goldman Sachs Puneet Souda - SVB Securities Brandon Couillard - Jefferies Daniel Brennan - Cowen Rachel Vatnsdal - JPMorgan Derik De Bruin - Bank of America Jack Meehan - Nephron Research Patrick Donnelly - Citigroup Joshua Waldman - Cleveland Research Dan Leonard - Credit Suisse Daniel Arias - Stifel Operator Ladies and gentlemen, welcome to the Agilent Technologies Q4 2022 Earnings Conference Call. My name is Bo and I will be coordinating your call today.
- 11/21/2022
|
Agilent Technologies (A) Q4 Earnings and Revenues Surpass Estimates
- Agilent (A) delivered earnings and revenue surprises of 10.07% and 4.66%, respectively, for the quarter ended October 2022. Do the numbers hold clues to what lies ahead for the stock?
- 11/21/2022
|
Agilent stock rallies after quarterly beat, outlook
- Agilent Technologies Inc. A, -0.72% shares rallied more than 4% after-hours Monday after the life-sciences electronics maker beat Wall Street expectations. Agilent earned $368 million, or $1.23 a share, compared with $442 million, or $1.45 a share, in the year-ago quarter.
- 11/21/2022
|
Agilent Q4 Preview: Double-Digit Earnings Growth in Store?
- Agilent has been the definition of consistency within its bottom-line results, exceeding earnings estimates in ten consecutive quarters.
- 11/18/2022
|
Agilent Technologies: A Quality Dividend Grower With Momentum Into 2023
- Agilent hiked its quarterly dividend rate by 7.1%, the 10th consecutive annual increase since 2012. We expect the company to report solid Q4 earnings on November 21st with firming margins as a key monitoring point.
- 11/18/2022
|
5 Stocks With Recent Dividend Hike for a Stable Portfolio
- Five stocks that recently hike their dividends are: GFF, GPI, A, SU and KEY.
- 11/18/2022
|
These Are the 10 Biggest Companies Issuing Earnings Next Week
- Over 90% of S&P 500 companies have reported their third quarter earnings as of last week.
- 11/17/2022
|
Agilent raises dividend by 7%
- Agilent Technologies Inc. A, -0.59% late Wednesday said it has increased its quarterly dividend to 22.5 cents a share, a 7% rise over the previous quarter. The dividend will be paid on Jan. 25 to shareholders of record as of Jan. 3, the life-sciences electronics maker said.
- 11/16/2022
|
3 Electronics Stocks With Upbeat Industry Prospects to Watch
- The Zacks Electronics -Testing Equipment industry players, such as A, AME and FTV, are poised well to benefit from 5G prospects and the growing potential in the pharmaceutical market.
- 11/16/2022
|
Agilent to Present at the Evercore ISI HealthCONx Conference
- SANTA CLARA, Calif.--( BUSINESS WIRE )--Agilent Technologies Inc. (NYSE: A) today announced that Mike McMullen, president and chief executive officer, and Bob McMahon, chief financial officer, will present at the 5th Annual Evercore ISI HealthCONx conference on Wednesday, November 30, at 10:50 a.m. PST.
- 11/15/2022
|
Agilent Remains In Buy Range Ahead Of Next Week's Q4 Report
- S&P 500 component Agilent Technologies remains in buy range, holding above short-term moving averages, ahead of next week's Q4 earnings report.
- 11/15/2022
|
Merck, Nike Among 14 Companies To Announce Annual Dividend Increases In The Second Half Of November
- There were a few double-digit boosts in the first half of November. Most notably, ADP came through with a 20% increase and Snap-On Tools with a 14% increase. Emerson extended its dividend growth streak to 66 years with a 1% boost and Lancaster Colony started its 7th decade of dividend growth with a 6% increase.
- 11/13/2022
|
Agilent to Announce Fourth-Quarter Fiscal Year 2022 Financial Results Nov. 21
- SANTA CLARA, Calif.
- 11/01/2022
|
Warning! Keep These 7 Dividend Stocks Out of Your Retirement Portfolio
- While high-yielding dividend stocks may provide the security investors want at this time, many of them could be dividend traps. These stocks come with high yields that are unlikely to be sustainable over the long term.There could also be a situation where a company may be paying more dividends than its net income.
- 10/28/2022
|
3 Stocks That Will Make You a Millionaire by 2030
- Before discussing stocks that will make you a millionaire, there is an important observation to discuss. One of the biggest changes in investing style over the decades is the average holding period.
- 10/28/2022
|
20X Winners Coming From
- Is crypto a “buy” again?
- 10/27/2022
|
7 Smart Stocks to Buy for an Income-Rich Retirement
- An income-rich retirement requires a lot of planning. There are many things that retirees must do in order to ensure that their golden years will be financially comfortable.
- 10/27/2022
|
Midterm Elections 2022: 3 Stocks to Avoid Like the Plague for a ‘Red Wave'
- Elections can be bad for investors. They create uncertainty.
- 10/27/2022
|
The 7 Biggest Cybersecurity Stocks Ranked From Best to Worst
- The prospects for cybersecurity stocks vary greatly. During the pandemic, few companies that provided cybersecurity services supported working from home.
- 10/26/2022
|
Is This Bull Market the Real Deal?
- Bullishness is back!
- 10/26/2022
|
7 Undervalued Blue-Chip Stocks to Buy Now
- Undervalued blue-chip stocks are a little easier to find in the midst of the current bear market. There are bargains to be found for investors who can stomach short-term volatility.
- 10/26/2022
|
Friday's Silly Rally
- Looking at last Friday's rally
- 10/25/2022
|
4 Under-the-Radar Tech Stocks Looking Good Right Now
- It's time we started studying the sector because valuations are running low.
- 10/17/2022
|
Agilent (A) Down 6.4% Since Last Earnings Report: Can It Rebound?
- Agilent (A) reported earnings 30 days ago. What's next for the stock?
- 09/15/2022
|
Agilent Confirmed Its Leadership And Is Set For Further Gains (Technical Analysis)
- Agilent reached the price target I suggested in April and is now showing even more strength. The stock is a leader in its industry and the healthcare sector is among the strongest in 3 months.
- 09/14/2022
|
Here's who could benefit from Biden's biotech initiative, according to Oppenheimer's Jared Holz
- Oppenheimer's Jared Holz on President Biden's cancer initiative and what it means for biotech in the U.S. With CNBC's Melissa Lee and the Fast Money traders, Tim Seymour, Courtney Garcia, Guy Adami and Karen Finerman.
- 09/12/2022
|
Agilent (A) to Penetrate Chromatography Market Via New Tie-Up
- Agilent (A) collaborates with Mettler Toledo to lessen errors during sample preparation for achieving better chromatographic results.
- 09/05/2022
|
Is the Options Market Predicting a Spike in Agilent Technologies (A) Stock?
- Investors need to pay close attention to Agilent Technologies (A) stock based on the movements in the options market lately.
- 08/23/2022
|
Agilent (A) Q3 Earnings Surpass Estimates, Revenues Rise Y/Y
- Agilent's (A) results for the fiscal third quarter reflect strong momentum in the pharma, and chemical & energy market.
- 08/17/2022
|
Agilent Technologies Proves Its Worth VS Illumina
- Agilent Technologies proved its worth in FQ3 and was able to raise guidance as well, sending its shares higher as it continues to outperform Illumina.
- 08/17/2022
|
Agilent Technologies, Inc. (A) CEO Mike McMullen on Q3 2022 Results - Earnings Call Transcript
- Agilent Technologies, Inc. (NYSE:A ) Q3 2022 Earnings Conference Call August 16, 2022 4:30 PM ET Company Participants Parmeet Ahuja - Investor Relations Mike McMullen - President and Chief Executive Officer Bob McMahon - Senior Vice President and Chief Financial Officer Jacob Thaysen - President, Agilent Life Science and Applied Markets Group Sam Raha - President, Agilent Diagnostics and Genomics Group Padraig McDonnell - President, Agilent CrossLab Group Conference Call Participants Matt Sykes - Goldman Sachs Brandon Couillard - Jefferies Vijay Kumar - Evercore ISI Puneet Souda - SVB Rachel Vatnsdal - JPMorgan Mike Ryskin - Bank of America Josh Waldman - Cleveland Research Jack Meehan - Nephron Research Elizabeth Garcia - UBS Patrick Donnelly - Citi Tim Daley - Wells Fargo Operator Good afternoon. Thank you for attending today's Agilent Technologies Q3 ‘22 Earnings Call.
- 08/16/2022
|
Agilent Technologies (A) Q3 Earnings and Revenues Beat Estimates
- Agilent (A) delivered earnings and revenue surprises of 11.67% and 4.85%, respectively, for the quarter ended July 2022. Do the numbers hold clues to what lies ahead for the stock?
- 08/16/2022
|
Agilent stock rallies after quarterly beat, guidance increase for company
- Shares of Agilent Technologies Inc. A, -0.84% rose more than 5% in the extended session Tuesday after the maker of lab instruments and other components reported fiscal third-quarter results above Wall Street expectations and raised guidance for the year. Agilent said it earned $329 million, or $1.10 a share, in the quarter, compared with $264 million, or 86 cents a share, in the year-ago period.
- 08/16/2022
|
Agilent Technologies Q3 Preview: Can the Earnings Streak Continue?
- The company has been on a blazing-hot earnings streak, chaining together nine consecutive bottom-line beats.
- 08/12/2022
|
Agilent Technologies: Turning Bullish Ahead Of Q3 Earnings
- Agilent is set to report its fiscal Q3 earnings on August 16th. Shares have been under pressure all year amid broader macro headwinds, despite continued growth and earnings momentum.
- 08/11/2022
|
Agilent to Announce Third-Quarter Fiscal Year 2022 Financial Results August 16
- SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced it will release financial results for the third quarter of fiscal year 2022 after the stock market closes on Tuesday, Aug. 16. The company will host a live webcast of its investor conference call in listen-only mode on the same day. Details for the webcast: Date: Tuesday, Aug. 16, 2022. Time: 1:30 p.m. Pacific time. Access: A link to join the webcast will be provided in the Upcoming Events section of Agile
- 07/19/2022
|
Earnings Growth & Price Strength Make Agilent Technologies (A) a Stock to Watch
- Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Focus List.
- 06/30/2022
|
Agilent Technologies Valuation Just Re-Entered 'Buy' Territory
- For investors who have been waiting to buy shares in Agilent, this is probably a good time to buy at least a starter position. For the last couple of years, Agilent had traded above what fundamentals justified, and now finally shares are priced to deliver very decent 8-9% returns.
- 06/27/2022
|
Agilent (A) Down 5.5% Since Last Earnings Report: Can It Rebound?
- Agilent (A) reported earnings 30 days ago. What's next for the stock?
- 06/23/2022
|
Agilent Technologies, Inc. (A) CEO Mike McMullen Presents at Goldman Sachs 43rd Annual Global Healthcare Conference (Transcript)
- Agilent Technologies, Inc. (NYSE:A ) Goldman Sachs 43rd Annual Global Healthcare Conference June 15, 2022 1:00 PM ET Company Participants Mike McMullen - Chief Executive Officer Bob McMahon - Chief Financial Officer Conference Call Participants Matt Sykes - Goldman Sachs Matt Sykes Okay. Great. Welcome, everybody.
- 06/21/2022
|
Agilent (A) to Provide Genomics Innovation Via New Tie-Ups
- Agilent (A) collaborates with Amazon's AWS and NVIDIA to provide advanced analytical solutions in the genomics space.
- 06/08/2022
|
Agilent to Participate in Goldman Sachs 43rd Annual Global Healthcare Conference
- SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the company will participate in the Goldman Sachs 43rd Annual Healthcare Conference on Wednesday, June 15, in Rancho Palos Verdes, California. President and CEO Mike McMullen and Chief Financial Officer Bob McMahon will represent the company in a fireside chat that begins at 10 a.m. PT/1 p.m. ET. A link to the live event will be available on Agilent's investor relations website and a replay will be provide
- 06/01/2022
|
Agilent (A) to Attract Biopharma Customers With APC Tie-Up
- Agilent (A) collaborates with APC Ltd. to combine their technologies and develop unique workflows to cater to the needs of customers in the biopharmaceutical and pharmaceutical industry.
- 05/31/2022
|
Here's Why Agilent Technologies (A) is a Strong Momentum Stock
- The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
- 05/31/2022
|
Earnings Growth & Price Strength Make Agilent Technologies (A) a Stock to Watch
- The Zacks Focus List offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.
- 05/31/2022
|
5 ETF Areas to Gain From Memorial Day 2022 & After
- Memorial Day Weekend is around the corner and will start the summer travel season. These ETF areas are likely to gain this year from the Memorial Day event.
- 05/27/2022
|
What Makes Agilent (A) a New Buy Stock
- Agilent (A) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
- 05/26/2022
|
Agilent (A) Stock Price: $161 Target And Outperform Rating
- The shares of Agilent (NYSE: A) have received a $161 price target from Baird. These are the details.
- 05/25/2022
|
Agilent (A) Q2 Earnings Surpass Estimates, Revenues Rise Y/Y
- Agilent's (A) results for the fiscal second quarter reflect strong momentum in the pharma and chemical & energy market.
- 05/25/2022
|
Top Stocks To Watch Right Now? 3 Tech Stocks In Focus
- Could these tech stocks be worth looking at as the tech sector attempts a recovery?
- 05/25/2022
|
Agilent Technologies Is Bottoming But Don't Buy It Yet
- Agilent Technologies (NASDAQ: A) had a good quarter in FQ2, and calendar Q1, but there is one glaring problem with the report. The company's results are good, and the outlook is good, but it's all priced into the stock and stock is still trading at over 25X its earnings.
- 05/25/2022
|
Agilent Technologies Inc. (A) CEO Mike McMullen on Q2 2022 Results - Earnings Call Transcript
- Agilent Technologies Inc. (NYSE:A ) Q2 2022 Results Conference Call May 24, 2022 4:30 PM ET Company Participants Parmeet Ahuja - VP, IR Mike McMullen - President and CEO Bob McMahon - SVP and CFO Jacob Thaysen - President, Life Sciences and Applied Markets Group Sam Raha - President, Diagnostics and Genomics Group Padraig McDonnell - President, CrossLab Group Conference Call Participants Vijay Kumar - Evercore ISI Matt Sykes - Goldman Sachs Brandon Couillard - Jefferies Puneet Souda - SVB Securities Derik De Bruin - Bank of America Patrick Donnelly - Citi Rachel Vatnsdal - JP Morgan Josh Waldman - Cleveland Research Jack Meehan - Nephron Research Daniel Arias - Stifel Catherine Schulte - Baird Operator Good afternoon and thank you for attending today's Agilent Technologies Inc. Q2 2022 Earnings Conference Call. My name is Selena, and I will be your moderator.
- 05/24/2022
|
Agilent Technologies (A) Q2 Earnings Beat Estimates
- Agilent (A) delivered earnings and revenue surprises of 1.80% and 0.33%, respectively, for the quarter ended April 2022. Do the numbers hold clues to what lies ahead for the stock?
- 05/24/2022
|
What's in the Cards for Agilent Technologies' (A) Q2 Earnings?
- Agilent Technologies' (A) fiscal second-quarter results are expected to reflect portfolio strength and momentum across all segments.
- 05/20/2022
|
Agilent Technologies (A) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
- Agilent (A) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 05/17/2022
|
Parnassus Comments on Agilent
- Agilent ( A , Financial) reduced the Fund's performance by -0.47%, as its shares delivered a negative total return of -17.0%. The company beat Wall Street's expectations and raised guidance, but the stock fell as secular growth companies trading at premium multiples de-rated relative to the market.
- 05/05/2022
|
Agilent to Announce Second-Quarter Fiscal Year 2022 Financial Results May 24
- SANTA CLARA, Calif.--(BUSINESS WIRE)---- $A #Agilent--Agilent Technologies Inc. (NYSE: A) today announced that it will release financial results for the second quarter of fiscal year 2022 after the stock market closes on Tuesday, May 24. The company will host a live webcast of its investor conference call in listen-only mode on the same day. Details for the webcast: Date: Tuesday, May 24, 2022. Time: 1:30 p.m. Pacific time. Access: Links to the webcast will be provided in the Upcoming Events section of Agilent
- 04/26/2022
|
Agilent: A Strong Leader With Great Opportunities
- Agilent looks fundamentally undervalued after losing 30% since its ATH. The company delivers consistently solid financial results and is forecasted to further increase its profitability.
- 04/15/2022
|
4 Testing Equipment Stocks to Escape a Challenging Industry
- Coronavirus--led disruptions are hurting the Zacks Electronics - Testing Equipment industry. However, industry participants like A, AME, FTV and CGNX are set to gain from 5G prospects.
- 04/12/2022
|
Agilent (A) Boosts PD-L1 IHC 28-8 pharmDX Use in European Union
- Agilent Technologies (A) boosts its presence in the companion diagnostics market by expanding the use of PD-L1 IHC 28-8 pharmDx assay for esophageal squamous cell carcinoma treatment in the EU.
- 04/07/2022
|
The FIW ETF: Because Water Is More Essential Than Oil (Or Data)
- The FIW ETF: Because Water Is More Essential Than Oil (Or Data)
- 03/31/2022
|
New to Investing? This 1 Computer and Technology Stock Could Be the Perfect Starting Point
- Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service.
- 03/22/2022
|
With Energy Security in Spotlight, ACES Has Allure
- Russia's ongoing war with Ukraine is among the reasons that oil prices are soaring this year. Those high prices and geopolitical tensions are reminders that, for many nations, energy security is an essential element in broader national security plans.
- 03/15/2022
|
New to Investing? This 1 Computer and Technology Stock Could Be the Perfect Starting Point
- The Zacks Focus List offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.
- 03/11/2022
|
Down 5.6% in 4 Weeks, Here's Why Agilent (A) Looks Ripe for a Turnaround
- Agilent (A) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
- 02/24/2022
|
Agilent (A) Q1 Earnings & Revenues Beat Estimates, Rise Y/Y
- Agilent's (A) fiscal first-quarter results benefit from solid momentum across all operating segments. Further, strong growth in the pharma market remains a tailwind.
- 02/23/2022
|
Agilent Technologies, Inc.'s (A) CEO Mike McMullen on Q1 2022 Results - Earnings Call Transcript
- Agilent Technologies, Inc.'s (A) CEO Mike McMullen on Q1 2022 Results - Earnings Call Transcript
- 02/22/2022
|
Agilent Technologies (A) Q1 Earnings and Revenues Beat Estimates
- Agilent (A) delivered earnings and revenue surprises of 3.42% and 1.30%, respectively, for the quarter ended January 2022. Do the numbers hold clues to what lies ahead for the stock?
- 02/22/2022
|
Benzinga's After-Hours Earnings Roundup: Agilent Technologies, Mosaic, Palo Alto Networks And More
- Benzinga's after-hours earnings roundup aims to deliver quick details about a company's earnings report, its forward-looking guidance and any other notable details. The list is handpicked by the reporters on the Benzinga Pro Newsdesk team.
- 02/22/2022
|
New to Investing? This 1 Computer and Technology Stock Could Be the Perfect Starting Point
- The Zacks Focus List offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.
- 02/03/2022
|
Test for Feed Earnings ESP
- Test for Feed Earnings ESP
- 01/04/2022
|
Test for feed 546 Tale of the Tape : Zacks Education Value Score
- 546 Tale of the Tape : Zacks Education Value Score
- 01/04/2022
|
Test Feed 547 Tale of the Tape : Zacks Education Growth Score
- 547 Tale of the Tape : Zacks Education Growth Score
- 01/04/2022
|
11 Dividend Increases To Start 2022 Including A Dividend King
- 11 Dividend Increases To Start 2022 Including A Dividend King
- 01/01/2022
|
Agilent Technologies (A) Outpaces Stock Market Gains: What You Should Know
- Agilent Technologies (A) closed at $160.65 in the latest trading session, marking a +0.92% move from the prior day.
- 12/29/2021
|
Agilent Technologies (A) Outpaces Stock Market Gains: What You Should Know
- Agilent Technologies (A) closed at $156.78 in the latest trading session, marking a +1.83% move from the prior day.
- 12/22/2021
|
Why Is Agilent (A) Down 0.5% Since Last Earnings Report?
- Agilent (A) reported earnings 30 days ago. What's next for the stock?
- 12/22/2021
|
Agilent to Present at Goldman Sachs and J.P. Morgan Healthcare Conferences
- SANTA CLARA, Calif.--(BUSINESS WIRE)---- $A #Agilent--Agilent Technologies Inc. (NYSE: A) today announced the company will deliver presentations at the Goldman Sachs 14th Annual Healthcare CEOs Unscripted Conference and the J.P. Morgan 40th Annual Healthcare Conference. Both conferences will be webcast. Details are included below. Goldman Sachs 14th Annual Healthcare CEOs Unscripted Conference Date: Jan. 6, 2022 Time: 11 a.m. ET/8 a.m. PT Presenting for Agilent: Mike McMullen, Agilent chief executive officer B
- 12/14/2021
|
3 Electronics Stocks With Bright Industry Prospects to Watch
- The Zacks Electronics - Testing Equipment industry players, A, AME and TER, are poised well to benefit from 5G prospects and the ongoing work-from-home trend.
- 12/10/2021
|
Dividend Champions For December 2021
- Monthly update of the Dividend Champions List. 75 companies declared higher dividends in the past month, with an average increase of 8.55% over their previous payouts.
- 12/02/2021
|
Agilent to Present at Evercore ISI Virtual Healthcare Conference
- SANTA CLARA, Calif.--(BUSINESS WIRE)---- $A #Agilent--Agilent to present at Evercore ISI Virtual Healthcare Conference.
- 11/23/2021
|
Agilent's (A) Q4 Earnings & Revenues Beat Estimates, Rise Y/Y
- Agilent Technologies' (A) fourth-quarter fiscal 2021 results reflect a solid end-market momentum and strong growth across Americas and China.
- 11/23/2021
|
Agilent Technologies, Inc. (A) CEO Mike McMullen on Q4 2021 Results - Earnings Call Transcript
- Agilent Technologies, Inc. (A) CEO Mike McMullen on Q4 2021 Results - Earnings Call Transcript
- 11/22/2021
|
Recap: Agilent Technologies Q4 Earnings
- Agilent Technologies (NYSE:A) reported its Q4 earnings results on Monday, November 22, 2021 at 04:05 PM. Here's what investors need to know about the announcement.
- 11/22/2021
|
Agilent Technologies (A) Tops Q4 Earnings and Revenue Estimates
- Agilent (A) delivered earnings and revenue surprises of 3.42% and 0.40%, respectively, for the quarter ended October 2021. Do the numbers hold clues to what lies ahead for the stock?
- 11/22/2021
|
Dividend Increases: November 13-19, 2021
- This weekly article series covers dividend changes. A summary table presents relevant data and key statistics of dividend increases.
- 11/21/2021
|
Agilent (A) to Report Q4 Earnings: What's in the Offing?
- Agilent's (A) fiscal fourth-quarter results are expected to reflect portfolio strength and momentum across all segments.
- 11/18/2021
|
Ackman Axes Agilent Technologies in 3rd Quarter
- Bill Ackman (Trades, Portfolio) has revealed his portfolio for the third quarter of 2021. The quarter saw Ackman sell out of his Agilent Technologies Inc. ( A , Financial) holding and make additions to his Chipotle Mexican Grill Inc. ( CMG , Financial), Domino's Pizza Inc. ( DPZ , Financial), Lowe's Companies Inc. ( LOW , Financial) and Hilton Worldwide Holdings Inc. ( HLT , Financial) positions.
- 11/16/2021
|
4 Top Analyst Stock Picks With Dividend Hikes Expected This Week
- After years of a low interest rate environment, many investors have turned to equities not only for the growth potential but also for solid and dependable dividends, which help to provide an income stream.
- 11/16/2021
|
Why Earnings Season Could Be Great for Agilent (A)
- Agilent (A) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
- 11/16/2021
|
Agilent Technologies (A) Reports Next Week: Wall Street Expects Earnings Growth
- Agilent (A) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 11/15/2021
|
Second Half Of November Brings Dividend Increases From Merck, Nike And 12 Others
- Investors saw a few very good dividend increases in the first half of November, with ADP, Snap-on, and Roper Technologies announcing double-digit boosts, and a massive 29% boost from HP. The second half of November will bring double-digit boosts from a few more companies including Nike, Motorola Solutions, Aflac, and Agilent Technologies.
- 11/15/2021
|
Agilent Technologies (A) Dips More Than Broader Markets: What You Should Know
- Agilent Technologies (A) closed the most recent trading day at $159.81, moving -0.7% from the previous trading session.
- 11/09/2021
|
Why the Earnings Surprise Streak Could Continue for Agilent (A)
- Agilent (A) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- 11/01/2021
|
Stocks This Week: Buy ProShares Ultra QQQ And Agilent Technologies
- Here are trading recommendations for this coming strong week.
- 10/31/2021
|
ECLUSIVE: Agilent Commits to Net-Zero Greenhouse Gas Emissions By 2050
- Agilent Technologies Inc (NYSE: A) has committed to achieving net-zero greenhouse gas emissions no later than 2050. Agilent has also committed to interim greenhouse gas reduction targets.
- 10/27/2021
|
ETFs to Ride on a Solid Start to Q3 Earnings
- The rounds of upbeat earnings has set the stage for the S&P 500 Index to hit new highs as more Q3 earnings unfold.
- 10/20/2021
|
Agilent Receives FDA Companion Diagnostic Approval for Ki-67 IHC MIB-1 pharmDx in High-Risk Early Breast Cancer
- SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced its Ki-67 IHC MIB-1 pharmDx (Dako Omnis) is now FDA approved as an aid in identifying patients with early breast cancer (EBC) at high risk of disease recurrence, for whom adjuvant treatment with Verzenio® (abemaciclib) in combination with endocrine therapy is being considered. This is the first IHC assay measuring Ki-67 expression to receive FDA approval in the context of treatment with Verzenio and was de
- 10/13/2021
|
Dividend Champion And Contender Highlights: Week Of September 26
- A weekly summary of dividend activity for Dividend Champions and Contenders.
- 09/26/2021
|
Dr. Mikael Dolsten Named to Agilent Board of Directors
- SANTA CLARA, Calif.--(BUSINESS WIRE)---- $A #Agilent--Pfizer executive Dr. Mikael Dolsten appointed to Agilent board of directors.
- 09/23/2021
|
New to Investing? This 1 Computer and Technology Stock Could Be the Perfect Starting Point
- Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service.
- 09/17/2021
|
Agilent (A), Visiopharm Unite for Supply of Pathology Solutions
- Agilent (A) signs an agreement with Visiopharm to globally distribute their pathology solutions.
- 09/03/2021
|
Has Agilent Technologies (A) Outpaced Other Computer and Technology Stocks This Year?
- Is (A) Outperforming Other Computer and Technology Stocks This Year?
- 09/03/2021
|
3 Stocks Growing Free Cash Flow Fast
- If you are screening the market for investment opportunities among U.S.-listed equities, you may want to consider the stocks listed below, as they have seen their free cash flow (FCF) grow notably over recent years. As a result, these businesses should be flexible enough to continue to support the development of projects and return cash to shareholders.
- 09/03/2021
|
Agilent to Present at Wells Fargo Virtual Healthcare Conference
- SANTA CLARA, Calif.--(BUSINESS WIRE)---- $A #Agilent--Agilent to present at 2021 Wells Fargo Virtual Healthcare Conference.
- 09/01/2021
|
Agilent Technologies (A) Boasts Earnings & Price Momentum: Should You Buy?
- Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service.
- 09/01/2021
|
Ackman committed to finding a deal for PSTH; sold Agilent to raise cash
- Billionaire investor William Ackman, who last year launched the biggest-ever special-purpose acquisition company, said on Tuesday he remains committed to finding a merger partner for his blank-check company Pershing Square Tontine Holdings Ltd (PSTH).
- 08/24/2021
|
Goldman Sachs Boosts Price Targets on 4 Strong Buy-Rated Stocks
- With August almost over and the back-to-school season upon us, the lion's share of the outstanding second-quarter earnings results have been posted, and analysts and investors on Wall Street are very satisfied with the results.
- 08/24/2021
|
Agilent Companion Diagnostic Expands CE-IVD Mark in Europe to Include Esophageal Cancer
- SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that the company's PD-L1 IHC 22C3 pharmDx assay has expanded its use in Europe. The assay is now CE-IVD marked for use as an aid in identifying esophageal cancer patients for treatment with KEYTRUDA using Combined Positive Score (CPS) ≥ 10.1 In Europe, KEYTRUDA is approved in combination with platinum- and fluoropyrimidine-based chemotherapy for patients with locally advanced unresectable or metastatic eso
- 08/23/2021
|
Agilent Technologies: Momentum In Genomics Keeps It Interesting
- Agilent Technologies: Momentum In Genomics Keeps It Interesting
- 08/22/2021
|
Agilent CEO confident on the growth of the company's non-Covid business
- Agilent CEO Mike McMullen told CNBC's Jim Cramer on Wednesday he's confident in the life sciences company's core business growth.
- 08/18/2021
|
Agilent (A) Q3 Earnings & Revenues Beat Estimates, Rise Y/Y
- Agilent's (A) fiscal third-quarter results benefit from strength across all geographical regions, business groups and end-market momentum.
- 08/18/2021
|
Agilent Stock Trading At 52-Week High As Analysts Beef Up Target Price After Q3 Earnings
- Agilent Technologies Inc (NYSE: A) reported third-quarter revenue of $1.59 billion, +26% and up 21% on a core basis, slightly beating the consensus of $1.54 billion. During the third quarter, revenues for the diagnostic and genomics group (DGG) rose 44% to $346 million.
- 08/18/2021
|
Agilent Technologies, Inc. (A) CEO Mike McMullen on Q3 2021 Results - Earnings Call Transcript
- Agilent Technologies, Inc. (A) CEO Mike McMullen on Q3 2021 Results - Earnings Call Transcript
- 08/17/2021
|
Agilent Technologies (A) Q3 Earnings and Revenues Surpass Estimates
- Agilent (A) delivered earnings and revenue surprises of 11.11% and 3.67%, respectively, for the quarter ended July 2021. Do the numbers hold clues to what lies ahead for the stock?
- 08/17/2021
|
Recap: Agilent Technologies Q3 Earnings
- Shares of Agilent Technologies (NYSE:A) fell 0.6% in after-market trading after the company reported Q3 results. Quarterly Results Earnings per share were up 41.03% year over year to $1.10, which beat the estimate of $0.99.
- 08/17/2021
|
Agilent Reports Third-Quarter Fiscal Year 2021 Financial Results
- SANTA CLARA, Calif.--(BUSINESS WIRE)---- $A #Agilent--Agilent reports strong fiscal third quarter financial results, raises full-year guidance.
- 08/17/2021
|
Agilent (A) to Report Q3 Earnings: What's in the Cards?
- Agilent's (A) fiscal third-quarter results are likely to reflect strength across its segments and product portfolio.
- 08/16/2021
|
Agilent Technologies (A) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
- Agilent (A) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 08/10/2021
|
5 Corporate Giants to Buy Ahead of Earnings Results This Month
- Five corporate bigwigs are slated to release their earnings results this month. These are: WMT, A, TGT, DE and ULTA.
- 08/06/2021
|
Agilent Earns 2021 Great Place to Work Certification in the U.S.
- SANTA CLARA, Calif.--(BUSINESS WIRE)---- $A #Agilent--Agilent earns 2021 Great Place to Work certification in the U.S.
- 08/04/2021
|
Agilent Announces Target Enrichment Manufacturing Facility in China
- SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that is has established in-country manufacturing for its SureSelect portfolio at its facility in Hangzhou, China. Agilent is a leading provider of next-generation sequencing assays, and customers often develop custom panels for their routine applications. Therefore, delivery turnaround time is an essential aspect of how Agilent uniquely serves its customers, enabling them to validate and implement their as
- 08/03/2021
|
Are You Looking for a Top Momentum Pick? Why Agilent Technologies (A) is a Great Choice
- Does Agilent Technologies (A) have what it takes to be a top stock pick for momentum investors? Let's find out.
- 08/02/2021
|
Can Agilent (A) Keep the Earnings Surprise Streak Alive?
- Agilent (A) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- 08/02/2021
|
3 Stocks With Price and Earnings Estimate Momentum
- 3 Stocks With Price and Earnings Estimate Momentum
- 07/30/2021
|
Agilent Technologies Celebrates More than 20 Years of Sustainable Progress
- SANTA CLARA, Calif.--(BUSINESS WIRE)---- $A #Agilent--Agilent issues 2020 corporate social responsibility report.
- 07/22/2021
|
Agilent (A) Expands pharmDX Assay Use in the European Union
- Agilent Technologies (A) expands the use of PD-L1 IHC 22C3 pharmDx assay for cancer treatment in the European Union.
- 07/21/2021
|
Agilent PD-L1 IHC 22C3 pharmDx Expands CE-IVD mark in Non-small Cell Lung Cancer (NSCLC)
- SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that the company's PD-L1 IHC 22C3 pharmDx assay is now labeled for expanded use in patients with non-small cell lung cancer (NSCLC) in the European Union. PD-L1 IHC 22C3 pharmDx can now be used as an aid in identifying NSCLC patients with tumor PD-L1 expression of Tumor Proportion Score (TPS) ≥ 50% for treatment with Libtayo® (cemiplimab). This announcement underscores Agilent's continuing commitment to th
- 07/20/2021
|
What Makes Agilent Technologies (A) a Strong Momentum Stock: Buy Now?
- Does Agilent Technologies (A) have what it takes to be a top stock pick for momentum investors? Let's find out.
- 07/05/2021
|
Agilent Technologies (A) Boasts Earnings & Price Momentum: Should You Buy?
- Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service.
- 07/05/2021
|
Macquarie Asset Management and Wilshire Expand Access to Private Market Investment Solutions for Accredited Investors with the Launch of Delaware Wilshire Private Markets Fund
- PHILADELPHIA & SANTA MONICA, Calif.--(BUSINESS WIRE)--Macquarie Asset Management (Macquarie) and Wilshire Advisors LLC (Wilshire) today announced that Delaware Wilshire Private Markets Fund (the Fund), a first-of-its-kind offering, is available for accredited investors, providing efficient access to an institutional-quality diversified private markets portfolio, including private equity, private credit, alternative yield, and private real assets. “The launch of Delaware Wilshire Private Markets
- 06/24/2021
|
Agilent (A) Expands Presence in LC Market With New Systems
- Agilent (A) expands its Bio Liquid Chromatography solutions portfolio with three new systems to fulfil the needs of biopharma industry.
- 06/23/2021
|
Agilent Completes the InfinityLab Bio LC Portfolio
- SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the launch of three InfinityLab Bio LC systems specifically developed to meet the needs of the biopharma industry. The release is central to the Agilent portfolio of complete Bio LC solutions, featuring instruments, columns, and supplies that seamlessly integrate with Agilent OpenLab and MassHunter software, and CrossLab services to maximize efficiency in biopharma labs. The three new systems include the 1
- 06/22/2021
|
New to Investing? This 1 Computer and Technology Stock Could Be the Perfect Starting Point
- Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service.
- 06/18/2021
|
Is Agilent Technologies (A) Stock Outpacing Its Computer and Technology Peers This Year?
- Is (A) Outperforming Other Computer and Technology Stocks This Year?
- 06/17/2021
|
Surging Earnings Estimates Signal Upside for Agilent (A) Stock
- Agilent (A) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
- 06/14/2021
|
Cell-Free DNA Guided Targeted Therapy Leads to Better Survival in Advanced Non-Small Cell Lung Cancer
- SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced a presentation by Memorial Sloan Kettering Cancer Center (MSK) at the upcoming annual meeting of the American Society of Clinical Oncology (ASCO) to discuss the Resolution ctDx Lung, a laboratory-developed test (LDT) developed by Resolution Bioscience. The presentation titled Overall survival with circulating tumor DNA-guided therapy in advanced non-small cell lung cancer will present evidence for the clin
- 06/04/2021
|
Agilent: Expensive, Yet Safe Bet
- Agilent has been a stealth value-creating play over the past years.
- 06/01/2021
|
Agilent's 4th Consecutive Beat on Earnings Boosts Stock
- On the heels of a bang-up second quarter, Agilent Technologies Inc. (A) shares climbed more than 3% to $137.58 on Thursday. The Santa Clara, California-based provider of application-focused solutions to the life sciences, diagnostics and applied chemical markets has beaten earnings estimates in each of the past four quarters.
- 05/27/2021
|
Agilent (A) Q2 Earnings & Revenues Beat Estimates, Rise Y/Y
- Agilent's (A) fiscal second-quarter results benefit from strength across all geographical regions and end-market momentum.
- 05/26/2021
|
What 12 Analyst Ratings Have To Say About Agilent Technologies
- Analysts have provided the following ratings for Agilent Technologies (NYSE:A) within the last quarter: Last 30 Days 1 Month Ago 2 Months Ago 3 Months Ago Bullish 1 0 0 1 Somewhat Bullish 4 0 0 0 Indifferent 0 0 0 0 Somewhat Bearish 0 0 0 0 Bearish 0 0 0 0 In the last 3 months, 12 analysts have offered 12-month price targets for Agilent Technologies. The company has an average price target of $145.08 with a high of $160.00 and a low of $135.00.
- 05/26/2021
|
Agilent Technologies Inc. (A) CEO Mike McMullen on Q2 2021 Results - Earnings Call Transcript
- Agilent Technologies Inc. (A) CEO Mike McMullen on Q2 2021 Results - Earnings Call Transcript
- 05/25/2021
|
Agilent Technologies (A) Q2 Earnings and Revenues Beat Estimates
- Agilent (A) delivered earnings and revenue surprises of 18.29% and 9.91%, respectively, for the quarter ended April 2021. Do the numbers hold clues to what lies ahead for the stock?
- 05/25/2021
|
Recap: Agilent Technologies Q2 Earnings
- Shares of Agilent Technologies (NYSE:A) rose in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share rose 36.62% over the past year to $0.97, which beat the estimate of $0.83.
- 05/25/2021
|
Agilent Reports Second-Quarter Fiscal Year 2021 Financial Results
- SANTA CLARA, Calif.--(BUSINESS WIRE)---- $A #Agilent--Agilent announces second quarter financial results; raises full-year guidance.
- 05/25/2021
|
Earnings Outlook For Agilent Technologies
- Agilent Technologies (NYSE:A) unveils its next round of earnings this Tuesday, May 25. Here is Benzinga's everything-that-matters guide for the earnings announcement.
- 05/24/2021
|
Agilent (A) to Report Q2 Earnings: What's in the Offing?
- Agilent's (A) fiscal second-quarter results are expected to reflect portfolio strength and end-market momentum.
- 05/20/2021
|
Agilent to Present at Jefferies Virtual Healthcare Conference
- SANTA CLARA, Calif.--(BUSINESS WIRE)---- $A #A--Agilent to present at Jefferies Virtual Healthcare Conference June 1.
- 05/20/2021
|
Agilent Announces Cash Dividend of 19.4 Cents per Share
- SANTA CLARA, Calif.--(BUSINESS WIRE)---- $A #Agilent--Agilent announces quarterly dividend.
- 05/19/2021
|
Agilent Technologies (A) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
- Agilent (A) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 05/18/2021
|
Macquarie Asset Management Appoints Michael Kopfler Global Head of Equity Trading
- PHILADELPHIA--(BUSINESS WIRE)--Macquarie Asset Management today announced the appointment of Michael Kopfler as Global Head of Equity Trading reporting to John Leonard, Global Head of Equities at the firm. In this role, Michael will be responsible for the strategic direction, daily operation, and management of Macquarie Asset Management's global equity trading desk, including maximizing technology and analytics and implementing innovative trading solutions to enhance client outcomes. “Michael b
- 05/13/2021
|
6 Must-Buy Stocks Ahead of Earnings Results This Month
- We have narrowed down our search to six major stocks likely to gain on earnings results. These are TGT, RL, KSS, NVDA, HPQ and A.
- 05/07/2021
|
5 Cheap Growth Stocks for Q2 2021
- After a brief selloff in Q1 2021, growth stocks are once again in focus. Investors can take advantage of this by investing in growth companies trading at low valuations.
- 05/06/2021
|
Agilent to Webcast Second-Quarter Fiscal Year 2021 Financial Results Presentation
- SANTA CLARA, Calif.--(BUSINESS WIRE)---- $A #Agilent--Agilent to announce fiscal second quarter financial results on May 25.
- 05/03/2021
|
Agilent LC/MS Instruments Receive ACT Labels from My Green Lab
- SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) announced today that both the InfinityLab LC/MSD iQ and the Ultivo Triple Quadrupole LC/MS systems have earned the highly-respected Accountability, Consistency and Transparency (ACT) Label from My Green Lab, a nonprofit organization dedicated to improving the sustainability of scientific research. “Agilent's mission is to provide trusted answers and insights that advance the quality of life, and sustainability is an impor
- 04/22/2021
|
Agilent Named One of the Best U.S. Companies for Diversity for Third Straight Year
- SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies (NYSE: A) today was named one of the top U.S. companies for diversity, marking the third straight year it has been recognized for its commitment to fostering a diverse and inclusive workplace. Specifically, Agilent ranked No. 83 out of 500 companies on Forbes's 2021 list of America's Best Employers for Diversity. The rating was based on dimensions of diversity including gender, ethnicity, LGBTQ+, age, and the differently abled. Agilent
- 04/20/2021
|
Macquarie Asset Management Launches “The Sharpe Advisor” Digital Educational Platform for Advisors Centered Around Private Markets
- PHILADELPHIA--(BUSINESS WIRE)--Macquarie Asset Management (“MAM”) today announced the launch of The Sharpe Advisor, a specialized digital resource for financial advisors that provides comprehensive educational content on private markets. With education as a key driver of success in bringing alternative investment solutions to financial advisors and their clients, Macquarie Asset Management aims to serve advisors with a practical guide to private markets investing with specialized content from i
- 04/19/2021
|
Agilent Named One of Singapore's Best Employers
- SINGAPORE--(BUSINESS WIRE)--Agilent Technologies announced that Agilent Singapore has been recognized as one of Singapore's Best Employers in 2021 for the second year-in-a-row.
- 04/13/2021
|
Agilent (A) Moves to Strong Buy: Rationale Behind the Upgrade
- Agilent (A) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
- 04/08/2021
|
Agilent Leveraged To Post-Pandemic Recovery And Advanced Drug Discovery And Production
- Agilent isn't a conventionally cheap stock, but should offer above-average revenue growth and margin expansion over the next five to 10 years, with leverage to several growth segments with biopharma. Agilent has been gaining share in instruments and demand should improve as lab activities and budgets normalize after the pandemic, with automation a longer-term growth driver.
- 03/31/2021
|
Oxford BioDynamics signs supply and resale agreement with Agilent Technologies, and launches EpiSwitch® Explorer Array Kit for R&D use
- OXFORD, England--(BUSINESS WIRE)--Oxford BioDynamics Plc (AIM: OBD, the Company), a biotechnology company developing precision medicine tests for personalized healthcare based on the EpiSwitch® 3D genomics platform, and Agilent Technologies (NYSE: A), a global leader in the life sciences, diagnostics, and applied chemical markets, have signed a supply and resale agreement for the manufacture and sale of the new EpiSwitch® Explorer Array Kit (“Kit”). Under the terms of the agreement, Agilent wil
- 03/31/2021
|
Bill Ackman's Pershing Square 2020 Annual Letter to Shareholder
- To the Shareholders of Pershing Square Holdings, Ltd.: 2020 was the best year in the 17-year history of Pershing Square.
- 03/29/2021
|
Why Is Agilent (A) Down 5.8% Since Last Earnings Report?
- Agilent (A) reported earnings 30 days ago. What's next for the stock?
- 03/18/2021
|
Agilent Announces Cash Dividend of 19.4 Cents per Share
- SANTA CLARA, Calif.--(BUSINESS WIRE)---- $A #Agilent--Agilent announces quarterly dividend.
- 03/17/2021
|
Agilent (A) Boosts Intelligence Capability With a New Launch
- Agilent (A) unveils 8697 Headspace Sampler which unprecedented precision and strong connections.
- 03/16/2021
|
Agilent Technologies Announces Pricing of $850 Million of Senior Notes
- SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies announces pricing of $850 million of senior notes.
- 03/03/2021
|
Agilent Technologies Announces Proposed Offering of Senior Notes
- SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies announces proposed offering of senior notes.
- 03/03/2021
|
Agilent Announces Darlene Solomon Award Presented to University of Geneva Scientist Noemi Jiménez-Rojo
- SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that the recipient of the 2021 Darlene Solomon Award is Noemi Jiménez-Rojo, a postdoctoral fellow studying membrane biology, lipid diversity, and function at the University of Geneva. The award was presented at a virtual ceremony during the International Singapore Lipid Symposium (iSLS) being held March 1-5 in Singapore. “Multidisciplinary approaches that include mass spectrometry will be crucial in the fo
- 03/02/2021
|
Agilent PD-L1 IHC 22C3 pharmDx Receives Expanded FDA Approval in Non-small Cell Lung Cancer (NSCLC)
- SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that the U.S. Food and Drug Administration (FDA) has approved the company's PD-L1 IHC 22C3 pharmDx assay for expanded use in patients with non-small cell lung cancer (NSCLC). PD-L1 IHC 22C3 pharmDx can now be used as an aid in identifying NSCLC patients with tumor PD-L1 expression of Tumor Proportion Score (TPS) ≥ 50% for treatment with Libtayo® (cemiplimab-rwlc). This announcement underscores Agilent's co
- 02/22/2021
|
Bill Ackman Slims Down Top Holdings in 4th Quarter
- Bill Ackman ( Trades , Portfolio ), leader of Pershing Square Capital, has revealed his portfolio for the fourth quarter of 2020. The top five trades of the quarter were reductions made in Starbucks Corp. (NASDAQ:SBUX), Restaurant Brands International Inc. (NYSE:QSR), Lowe's Companies Inc. (NYSE:LOW), Agilent Technologies Inc. (NYSE:A) and Hilton Worldwide Holdings Inc. (NYSE:HLT).
- 02/19/2021
|
Agilent Ranks No. 2 on Barron's List of America's Most Sustainable Companies
- SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) has earned the number two position on Barron's annual list of America's Most Sustainable Companies. The ranking marks the third straight year Agilent has been included among the top three Most Sustainable Companies. Agilent has also received the number one ranking in the life sciences industry for each of the four years the Barron's ranking has been compiled. “We're very pleased to again be named one of America's Most Sus
- 02/18/2021
|
Agilent Announces Immunoassay Kit to Detect SARS-CoV-2 Antibodies
- SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the launch of the Agilent Dako SARS-CoV-2 IgG Enzyme-Linked Immunosorbent Assay (ELISA) kit intended for the qualitative detection of immunoglobulin G (IgG) antibodies to SARS-CoV-2 in human serum or plasma. The kit, which marks Agilent's entrance into SARS-CoV-2 testing in the US, has completed the notification process to FDA in accordance with Section IV.D of FDA's “Policy for Coronavirus Disease-2019 Te
- 02/18/2021
|
Agilent's (A) Q1 Earnings Beat Estimates, Revenues Up Y/Y
- Agilent Technologies' (A) fiscal first-quarter results reflect growth in all segments and regions served.
- 02/17/2021
|
Agilent Announces Higher-Sensitivity XF Analysis Solution for Low Abundant Immune Cell Metabolic Analysis
- SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today introduced the Agilent Seahorse XF HS Miniplate designed specifically for the Agilent Seahorse XF HS Mini Analyzer for improved immune cell metabolic analysis. Immunology and disease researchers are increasingly using rare, ex vivo, and genetically engineered cells to build better disease models. Limitations in the quantities of these cells that they can produce, however, restrict these researchers in the types of c
- 02/17/2021
|
Agilent Technologies Inc. (A) CEO Mike McMullen on Q1 2021 Results - Earnings Call Transcript
- Agilent Technologies Inc. (A) CEO Mike McMullen on Q1 2021 Results - Earnings Call Transcript
- 02/16/2021
|
Recap: Agilent Technologies Q1 Earnings
- Shares of Agilent Technologies (NYSE:A) moved higher after the company reported Q1 results. Quarterly Results Earnings per share rose 30.86% over the past year to $1.06, which beat the estimate of $0.89.
- 02/16/2021
|
Agilent Technologies shares up 2% on better-than-expected earnings, sales
- Shares of Agilent Technologies Inc. were up 2% in after-hours trading Tuesday after the life-sciences and diagnostics company reported fiscal first-quarter results. Agilent reported net income of $288 million, or 93 cents a share, compared with net income of $197 million, or 63 cents a share, in the year-ago quarter.
- 02/16/2021
|
Agilent Reports First-Quarter Fiscal Year 2021 Financial Results
- SANTA CLARA, Calif.--(BUSINESS WIRE)---- $A #AgilentQ1--Agilent announces strong first quarter financial results; raises outlook for full year.
- 02/16/2021
|
Is a Surprise Coming for Agilent (A) This Earnings Season?
- Agilent (A) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
- 02/12/2021
|
What's in the Offing for Agilent (A) This Earnings Season?
- Agilent's (A) strength in revenue segments is likely to reflect on fiscal first-quarter results.
- 02/12/2021
|
Agilent Technologies (A) Earnings Expected to Grow: Should You Buy?
- Agilent (A) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 02/09/2021
|
What Makes Agilent (A) a New Buy Stock
- Agilent (A) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
- 02/09/2021
|
Agilent to Present at Upcoming Investor Events; Provides Webcast Details for Annual Shareholder Meeting
- SANTA CLARA, Calif.--(BUSINESS WIRE)---- $A #Agilent--Agilent announces upcoming investor events and details for annual Shareholder Meeting.
- 02/08/2021
|
Agilent Wins Trade Secret and Patent Infringement Litigation
- SANTA CLARA, Calif.--(BUSINESS WIRE)---- $A #Agilent--Agilent wins trade secret and patent Infringement ruling; J&X Technologies to pay Agilent more than $1.25 million in damages.
- 02/01/2021
|
Agilent Technologies: Latest Guidance Increase Points Toward A Brighter Outlook
- Agilent raises its FQ1 '21 guide at the recent JPM conference on the back of broad-based strength across its segments and end-markets. The near-term outlook appears bright, underpinned by a cyclical rebound in the Life Science & Applied Markets business, along with continued resilience in the Cross Lab Group.
- 01/27/2021
|
Agilent to Webcast First-Quarter Fiscal Year 2021 Financial Results Presentation
- SANTA CLARA, Calif.--(BUSINESS WIRE)---- $A #Agilent--Agilent to issue first quarter fiscal year 2021 financial results Tuesday, Feb. 16.
- 01/26/2021
|
Agilent Announces Enhanced Mass Spectrometry and Automation Software Solutions to Support Regulatory Compliance Guidelines
- SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the release of MassHunter Workstation Plus 11.0, MassHunter Networked Workstation 11.0, and MassHunter BioConfirm. The latest revision of these software enables data integrity consistent with the regulatory requirements from the US FDA and EU EMEA guidance, providing user management, checksums, tamper detection, and audit trails for MassHunter Acquisition, Quantitative Analysis, and MassHunter BioConfirm.
- 01/25/2021
|
Agilent Names Allison Ballmer Senior Vice President of Strategy and Corporate Development
- SANTA CLARA, Calif.--(BUSINESS WIRE)---- $A #Agilent--Agilent names Allison Ballmer senior vice president of Strategy and Corporate Development.
- 01/15/2021
|
5 Health Care Stocks Gurus Are Buying
- According to the GuruFocus All-in-One Screener as of Jan. 15, the following Health Care stocks are popular among gurus.
- 01/15/2021
|
Why Is Agilent (A) Up 2.4% Since Last Earnings Report?
- Agilent (A) reported earnings 30 days ago. What's next for the stock?
- 12/23/2020
|
Agilent Receives Approval for GenetiSure Dx Postnatal Assay in Japan
- SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) announced it has obtained clearance from the Ministry of Health, Labour and Welfare (MHLW) in Japan for the GenetiSure Dx Postnatal Assay – a microarray-based assay for diagnostic use. This assay enables clinical geneticists to detect genetic aberrations associated with developmental delay, intellectual disabilities, congenital anomalies, and unexplained dysmorphic features. The company also announced that it has register
- 12/22/2020
|
Agilent Announces Webcasts for Investment Community
- SANTA CLARA, Calif.--(BUSINESS WIRE)---- $A #Agilent--Agilent announces investor webcasts.
- 12/16/2020
|
Agilent Receives Multiple Innovation Awards
- SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that both the NanoDis System and the innovative new style polychromator in the 5800 and 5900 ICP-OES have received Innovation Awards from The Analytical Scientist. The recently launched NanoDis System utilizes cross-flow filtration—a concept traditionally used in industrial process chemistry—combined with conventional dissolution instruments to enable nanoparticle dissolution testing. Along with the introd
- 12/14/2020
|
Agilent Releases 2019 Corporate Social Responsibility Report
- SANTA CLARA, Calif.--(BUSINESS WIRE)---- $A #Agilent--Agilent releases 2019 corporate social responsibility report.
- 12/11/2020
|
Agilent Presents Thought Leader Award to IIT Delhi Scientist Professor Anurag Rathore
- SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) has honored Prof. Anurag Rathore, a scientist at the Indian Institute of Technology (IIT) Delhi, with an Agilent Thought Leader Award, for his contributions to the field of biopharmaceutical research and his work with advanced methods for molecular characterization of biosimilars. The 2020 award includes a grant to support research personnel and Agilent instrumentation including a 6545XT AdvanceBio LC/Q-TOF, a Bravo Autom
- 12/07/2020
|
Agilent Announces Alissa Interpret Selected by North West Genomic Laboratory Hub for Clinical Genomic Analysis
- SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced its clinical informatics platform Alissa Interpret has been adopted by the North West Genomic Laboratory Hub (NW GLH) based in Manchester and Liverpool, part of Manchester University NHS Foundation Trust, England. The NW GLH and its partners are responsible for delivering genomic testing across the whole of the North West. Alissa Interpret, which enables clinical genetics labs to standardize and automate v
- 12/03/2020
|
Agilent Announces Launch of Global Biomarker Pathologist Training Program
- SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the launch of the Biomarker Pathologist Training Program, a global initiative created to empower pathologists to score biomarkers accurately and confidently. Developed by Agilent – a worldwide leader in developing and commercializing diagnostic products – this training program incorporates Agilent's unique expertise in companion diagnostics and partnership with top pharmaceutical companies. Biomarker testi
- 11/30/2020
|
Agilent Technologies Inc. (A) CEO Mike McMullen on Q4 2020 Results - Earnings Call Transcript
- Agilent Technologies Inc. (A) CEO Mike McMullen on Q4 2020 Results - Earnings Call Transcript
- 11/23/2020
|
Agilent Technologies: Q4 Earnings Insights
- Shares of Agilent Technologies (NYSE:A) fell 2.53% in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share rose 10.11% over the past year to $0.98, which beat the estimate of $0.93.
- 11/23/2020
|
Agilent Reports Fourth-Quarter and Fiscal Year 2020 Financial Results; Initiates Fiscal 2021 Guidance
- SANTA CLARA, Calif.--(BUSINESS WIRE)---- $A #Agilent--Agilent reports fourth-quarter and fiscal year 2020 financial results; initiates fiscal 2021 guidance.
- 11/23/2020
|
Dividend Changes: November 14-20, 2020
- In this article series, we provide a weekly summary of dividend changes. A summary table provides relevant data and key statistics of dividend increases.
- 11/23/2020
|
Agilent Launches New NanoDis System for Nanoparticle Dissolution Testing
- SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the introduction of the NanoDis System for nanoparticle dissolution testing. Combining Agilent instrumentation and software to enable customers to meet 21 CFR Part 11 and other regulations through its application, the new NanoDis System delivers a dedicated workflow that is automatable and auditable. Designed in collaboration with Dr. Emre Türeli from nanoparticle manufacturer MyBiotech GmbH, the NanoDis S
- 11/23/2020
|
Agilent Presents Thought Leader Award to Drs. Carl H. June and Michael Milone
- SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced professors Carl H. June, MD, and Michael Milone, MD, Ph.D., as recipients of an Agilent Thought Leader Award. Both scientists are being recognized for their joint contributions to the field of CAR T-cell mediated cancer immunotherapy, having codeveloped tisagenlecleucel (Kymriah™), the first cell and gene therapy product approved by the US FDA. The award will focus on defining standards for the design, val
- 11/17/2020
|
Agilent Receives Expanded FDA Approval for PD-L1 IHC 22C3 pharmDx in Triple-Negative Breast Cancer
- SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced it has received FDA approval for the use of PD-L1 IHC 22C3 pharmDx as an aid in identifying patients with triple-negative breast cancer (TNBC) for treatment with KEYTRUDA® (pembrolizumab). PD-L1 expression is a critical biomarker for response to anti-PD-1 therapies such as KEYTRUDA. The expanded use of PD-L1 IHC 22C3 pharmDx strengthens the ability of pathologists to identify patients who may be eligible f
- 11/13/2020
|
Agilent Collaborates With SGS to Release New US EPA Method for the Analysis of Dioxins Using GC/TQ
- SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) announced today a collaboration with SGS has resulted in a new GC/TQ method, the SGS AXYS Method 16130, approved by the US EPA as an alternative method for the future regulation and detection of dioxins. Dioxins are a group of chemical compounds that are considered persistent environmental pollutants and subsequently find their way into the food chain. These chemicals are listed as persistent organic pollutants under the
- 11/04/2020
|
Agilent to Webcast Fourth-Quarter Fiscal Year 2020 Financial Results Presentation, Sets Date for Virtual Analyst and Investor Meeting
- SANTA CLARA, Calif.--(BUSINESS WIRE)---- $A #Agilent--Agilent will release fiscal fourth quarter financial results Mon., Nov. 23. and will also host a virtual analyst and investor event Wed., Dec. 9.
- 10/29/2020
|
Bill Ackman Reduces Lowe's, Agilent Technologies and Hilton Worldwide Holdings
- Bill Ackman (Trades, Portfolio), leader of Pershing Square Capital Management, has revealed his portfolio for the third quarter.
- 10/26/2020
|
Pacer Advisors Inc. Sells 4,329 Shares of Agilent Technologies, Inc. (NYSE:A)
- Pacer Advisors Inc. lowered its stake in shares of Agilent Technologies, Inc. (NYSE:A) by 13.5% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 27,835 shares of the medical research company’s stock after selling 4,329 shares during the quarter. Pacer Advisors Inc.’s holdings in Agilent […]
- 10/22/2020
|
Agilent Technologies, Inc. (NYSE:A) Shares Purchased by IBM Retirement Fund
- IBM Retirement Fund boosted its stake in shares of Agilent Technologies, Inc. (NYSE:A) by 39.0% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 10,053 shares of the medical research company’s stock after buying an additional 2,821 shares during […]
- 10/20/2020
|
Validation of Bluestar Genomics’ Technology for Non-Invasive Detection of Pancreatic Cancer Published in Nature Communications
- Bluestar Genomics, an innovative company leading the development of next-generation epigenomic approaches to early cancer detection, announced today t
- 10/20/2020
|
Mission Wealth Management LP Buys 101 Shares of Agilent Technologies, Inc. (NYSE:A)
- Mission Wealth Management LP increased its stake in shares of Agilent Technologies, Inc. (NYSE:A) by 1.1% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 9,539 shares of the medical research company’s stock after acquiring an additional 101 shares during the quarter. Mission […]
- 10/19/2020
|
Quantum Genomics :
Quantum Genomics conclut un accord de licence et de collaboration exclusif avec Qilu Pharmaceutical | Zone bourse
|
QUANTUM GENOMICS : Quantum Genomics conclut un accord de licence et de collaboration exclusif avec Qilu Pharmaceutical
- Quantum Genomics recevra jusqu'à 50 M$ de paiements initiaux (upfront) et d'étapes (milestones) ainsi que des royalties à deux chiffres sur les ventes futures.
Qilu Pharmaceutical recevra une licence exclusive pour développer et commercialiser le firibastat pour le traitement de l'hypertension difficile à traiter / résistante en Chine, y compris Hong-Kong et Macao
- 10/19/2020
|
Agilent to Showcase Their Commitment to Sustainability at analytica virtual 2020
- Agilent Technologies Inc. (NYSE: A) today announced that their 1220, 1260, and 1290 Infinity II LC product families have received the My Green Lab acc
- 10/19/2020
|
Nachman Norwood & Parrott Inc Makes New Investment in Agilent Technologies Inc (NYSE:A)
- Nachman Norwood & Parrott Inc purchased a new position in Agilent Technologies Inc (NYSE:A) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 515 shares of the medical research company’s stock, valued at approximately $52,000. A number of other institutional investors and hedge funds […]
- 10/18/2020
|
COVID-19 Impact and Recovery Analysis |Laboratory Equipment Services Market Procurement Intelligence Report Forecasts Spend Growth of over USD 24 Billion
- Laboratory Equipment Services Market is poised to experience spend growth of more than USD 24 billion between 2020-2024 at a CAGR of over 6.23%.
- 10/18/2020
|
CX Institutional Purchases 299 Shares of Agilent Technologies Inc (NYSE:A)
- CX Institutional lifted its position in shares of Agilent Technologies Inc (NYSE:A) by 130.6% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 528 shares of the medical research company’s stock after acquiring an additional 299 shares during the period. CX […]
- 10/16/2020
|
Regentatlantic Capital LLC Sells 474 Shares of Agilent Technologies Inc (NYSE:A)
- Regentatlantic Capital LLC cut its holdings in Agilent Technologies Inc (NYSE:A) by 7.6% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 5,768 shares of the medical research company’s stock after selling 474 shares during the quarter. Regentatlantic Capital LLC’s holdings in […]
- 10/16/2020
|
Global Capillary Electrophoresis Market|Increasing R&D Expenditure to Boost Market Growth | Technavio
- The Global Capillary Electrophoresis Market will grow by $ 300.97 mn during 2020-2024
- 10/16/2020
|
Global Treatment and Diagnosis of Sexually Transmitted Diseases Markets, 2025 - Focus on Antibiotics, Antivirals/Antiretrovirals & EIA, ELISA, PCR, Rapid Diagnostics - ResearchAndMarkets.com
|
Agilent Technologies Inc (NYSE:A) Shares Acquired by Envestnet Asset Management Inc.
- Envestnet Asset Management Inc. grew its stake in Agilent Technologies Inc (NYSE:A) by 10.7% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 256,741 shares of the medical research company’s stock after purchasing an additional 24,832 shares during the period. Envestnet Asset […]
- 10/14/2020
|
Agilent Technologies Inc (NYSE:A) Stock Position Increased by LGT Capital Partners LTD.
- LGT Capital Partners LTD. increased its stake in shares of Agilent Technologies Inc (NYSE:A) by 3.3% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 829,680 shares of the medical research company’s stock after purchasing an additional 26,210 shares during the period. Agilent Technologies makes […]
- 10/13/2020
|
DNA Sequencing Market to Reach $ 12.5 bn by 2024, Agilent Technologies Inc., BGI Genomics Co. Ltd., and Thermo Fisher Scientific Inc., Emerge as Key Contributors to Growth | Technavio
- The Global DNA Sequencing Market will grow by USD 12.5 bn during 2020-2024
- 10/13/2020
|
Top Sector ETFs From Wall Street's Best Week in 3 Months
- Stocks Analysis by Zacks Investment Research covering: S&P 500, Xilinx Inc, NVIDIA Corporation, Advanced Micro Devices Inc. Read Zacks Investment Research's latest article on Investing.com
- 10/12/2020
|
Their Travel Dreams Upended, Retirees Adjust to the Pandemic. Here’s How Some Are Coping.
- Normally, travel is the top dream of retirees. But the coronavirus pandemic has changed many retirees’ travel plans, forcing them to adapt on the fly.
- 10/10/2020
|
Genomics Market| Need for Creating/Upgrading Genome Databases to Boost the Market Growth | Technavio
- The Global Genomics Market will grow by USD 17.23 bn during 2020-2024
- 10/09/2020
|
Agilent Technologies Inc (NYSE:A) Shares Sold by First Hawaiian Bank
- First Hawaiian Bank trimmed its holdings in shares of Agilent Technologies Inc (NYSE:A) by 2.6% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 12,496 shares of the medical research company’s stock after selling 336 shares during the quarter. First Hawaiian Bank’s holdings in […]
- 10/08/2020
|
Fulton Bank N. A. Has $654,000 Stock Position in Agilent Technologies Inc (NYSE:A)
- Fulton Bank N. A. grew its holdings in shares of Agilent Technologies Inc (NYSE:A) by 17.3% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 6,480 shares of the medical research company’s stock after buying an additional 957 shares during the quarter. […]
- 10/08/2020
|
Global Biosensors in Life Sciences Market Will Showcase Neutral Impact During 2020-2024 | Advantages of Biosensors in Drug Analysis to Boost Market Growth | Technavio
- The Global Biosensors in Life Sciences Market will grow by $ 2.32 bn during 2020-2024
- 10/08/2020
|
Global Womens Health Diagnostics Market Investment Feasibility 2029 With Top Manufactures - Agilent Technologies, Ariosa Diagnostics
- Oct 07, 2020 (WiredRelease via Comtex) --
Radical Growth of Global Womens Health Diagnostics Market Provides an updated and current analysis of the...
- 10/07/2020
|
COVID-19 Impact and Recovery Analysis | Laboratory Equipment Services Market Procurement Intelligence Report Forecasts Spend Growth of Over USD 24 Billion | SpendEdge
- Global Laboratory Equipment Services Market is poised to experience spend growth of more than USD 24 billion between 2020-2024 at a CAGR of over 6.23%
- 10/07/2020
|
Disruptive Technologies Are Enabling The Re-Opening Economy
- Sandwiched between the two extremes of the largely shut-down Stay-at-Home Economy and a fully opened New Normal Economy, the Re-Opening Economy is an uncertain, transitional phase.
- 10/06/2020
|
Wellcome Sanger Institute selecciona a Arima Genomics como su socio tecnológico de HiC; la compañía anuncia un programa de acceso temprano para la tecnología HiC de alta cobertura
- Arima Genomics, Inc., una compañía de biotecnología que tiene como objetivo acelerar la adopción de la información de la estructura del genoma, anunci
- 10/06/2020
|
Global Biomarkers Market Forecasts for Immuno-Oncology Diagnostics 2020-2024 with Executive and Consultant Guides - ResearchAndMarkets.com
|
Clinical Mass Spectrometry Market by End-User (Healthcare Facilities and Pharma and Biotech Companies and Research Labs and Institutes) and Geography (Asia, Europe, North America, and ROW) | COVID-19 Impact Analysis
- The Global Clinical Mass Spectrometry Market will grow by USD 1.70 bn during 2020-2024
- 10/03/2020
|
Global Single Cell Genomics Markets, 2020-2024 with COVID-19 Updates (Q3 2020) - ResearchAndMarkets.com
|
Global Laboratory Centrifuge Market Procurement Intelligence Report with COVID-19 Impact Analysis | Global Forecasts, 2020-2024
- The Global Laboratory Centrifuge market will register an incremental spend of about $292 million, growing at a CAGR of 3.42%
- 09/30/2020
|
COVID-19 Recovery Analysis: Protein Expression Market | Increasing Advances in Proteomics Research to Boost Market Growth | Technavio
- The Global Protein Expression Market will grow by $ 1.63 bn during 2020-2024
- 09/29/2020
|
Insights on the Predictive and Presymptomatic Testing Global Market to 2027 - Featuring Mapmygenome, Myriad Genetics & Pathway Genomics Among Others - ResearchAndMarkets.com
|
COVID-19 Recovery Analysis: Explosive Detection Equipment Market | Enhanced Security Mandate of Authorities to Boost the Market Growth | Technavio
- The Global Explosive Detection Equipment Market will grow by $ 2.72 bn during 2020-2024
- 09/23/2020
|
Quantum Genomics :
Quantum Genomics conclut un accord de licence et de collaboration exclusif avec Orient EuroPharma (OEP) | Zone bourse
|
Instrumentation Services Market: COVID-19 Business Continuity Plan | Evolving Opportunities With ABB Ltd. and Agilent Technologies Inc. | Technavio
- The Global Instrumentation Services Market will grow by $ 1.31 bn during 2020-2024
- 09/22/2020
|
AdvisorNet Financial Inc Has $113,000 Position in Agilent Technologies Inc (NYSE:A)
- AdvisorNet Financial Inc reduced its position in shares of Agilent Technologies Inc (NYSE:A) by 10.3% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,282 shares of the medical research company’s stock after selling 148 shares during the period. AdvisorNet Financial Inc’s […]
- 09/21/2020
|
Laboratory Equipment Services Market Procurement Intelligence Report with COVID-19 Impact Analysis | Global Forecasts, 2020-2024
- The Laboratory Equipment Services market will register an incremental spend of about $24 billion, growing at a CAGR of 6.23%.
- 09/21/2020
|
Tracking William Nygren's Harris Associates Portfolio - Q2 2020 Update (MUTF:OAKMX)
- Harris Associates 13F portfolio value increased from $36.11B to $41.11B this quarter. They increased Workday while reducing Regeneron Pharmaceuticals.
- 09/17/2020
|
Agilent Technologies Inc (NYSE:A) Shares Sold by Fmr LLC
- Fmr LLC decreased its stake in shares of Agilent Technologies Inc (NYSE:A) by 5.0% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 353,733 shares of the medical research company’s stock after selling 18,800 shares during the quarter. Fmr LLC owned about 0.11% […]
- 09/17/2020
|
Chromatography Market- Roadmap for Recovery from COVID-19 | Growing Demand For Portable Analytical Systems to boost the Market Growth | Technavio
- The Global Chromatography Market will grow by $ 4.13 bn during 2020-2024
- 09/17/2020
|
In Vitro Diagnostic (IVD) Reagents (Antibodies, Oligonucleotide, Nucleic Acid Probe) Market - Global Forecast to 2027 - ResearchAndMarkets.com
|
Spectrophotometer Market: COVID-19 Business Continuity Plan | Evolving Opportunities With Agilent Technologies Inc. and Avantor Inc. | Technavio
- The Global Spectrophotometer Market will grow by $ 869.24 mn during 2020-2024
- 09/15/2020
|
Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q2 2020 Update
- Halvorsen's 13F portfolio value increased from $19.21B to $23.14B. The number of positions increased from 64 to 71.
- 09/11/2020
|
Wall Street Breakfast: The Week Ahead
- Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify.
- 09/06/2020
|
Stocks To Watch: Tech Reboots And Eyes On Lululemon, Peloton & GameStop
- Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning.
- 09/05/2020
|
Tracking Bill Ackman's Pershing Square Portfolio - Q2 2020 Update
- Bill Ackman’s 13F portfolio value increased from $6.57B to $7.75B this quarter. Pershing Square increased Restaurant Brands while dropping Berkshire Hathaway during the quarter.
- 09/02/2020
|
Pershing Square Holdings Semi-Annual Letter To Shareholders
- Pershing Square Holdings, Ltd. is a closed-ended investment company.
- 08/31/2020
|
Virtu Financial LLC Buys Shares of 2,379 Agilent Technologies Inc (NYSE:A)
- Virtu Financial LLC acquired a new stake in Agilent Technologies Inc (NYSE:A) in the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 2,379 shares of the medical research company’s stock, valued at approximately $210,000. Other institutional investors also recently bought and sold […]
- 08/27/2020
|
Agilent Sets the Standard in Customer Flexibility with Analytical Technology Subscription Model
- Agilent Technologies Inc. (NYSE: A) today announced its first-ever instrument subscription program, designed to meet the needs of customers with dynam
- 08/27/2020
|
Global Genetic Testing Market Size Forecast to 2023 - ResearchAndMarkets.com
|
$0.91 Earnings Per Share Expected for Agilent Technologies Inc (NYSE:A) This Quarter
- Wall Street analysts expect Agilent Technologies Inc (NYSE:A) to report earnings per share (EPS) of $0.91 for the current fiscal quarter, according to Zacks. Five analysts have issued estimates for Agilent Technologies’ earnings. The lowest EPS estimate is $0.85 and the highest is $1.00. Agilent Technologies reported earnings of $0.89 per share during the same […]
- 08/25/2020
|
Global Anatomic Pathology Market Analysis 2020-2025 - by Product & Service, Consumables, Application, End User and Region - ResearchAndMarkets.com
|
COVID-19 Impacts: Global Metabolomics Market will Accelerate at a CAGR of over 12% through 2020-2024 | Increased Adoption in the Field of Precision Medicine to Boost Growth | Technavio
- The Global Metabolomics Market will grow by $ 1.54 bn during 2020-2024
- 08/22/2020
|
Tech, Tesla, and Apple Star as Stocks Keep Rising
- Electric-car company and iPhone maker hit new highs before their scheduled splits. Also, how to play it safe with dividend-paying shares, and what might happen at a post-Buffett Berkshire Hathaway.
- 08/21/2020
|
Agilent Technologies, Inc. 2020 Q3 - Results - Earnings Call Presentation
- The following slide deck was published by Agilent Technologies, Inc. in conjunction with their 2020 Q3 earnings call..
- 08/19/2020
|
P/E Ratio Insights for Agilent Technologies
- In the current session, Agilent Technologies Inc. (NYSE: A) is trading at $98.94, after a 1.13% increase. Over the past month, the stock increased by 2.82%, and in the past year, by 38.10%. With performance like this, long-term shareholders optimistic but others are more likely to look into the price-to-earnings ratio to see if the stock might be overvalued.Assuming that all other factors are held constant, this could present itself as an opportunity for shareholders trying to capitalize on the higher share price. The stock is currently below from its 52 week high by 0.43%.The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against its past earnings, historical data and aggregate market data for the industry or the indices, such as S&P 500. A higher P/E indicates that investors expect the company to perform better in the future, and the stock is probably overvalued, but not necessarily. It also shows that investors are willing to pay a higher share price currently, because they expect the company to perform better in the upcoming quarters. This leads investors to also remain optimistic about rising dividends in the future.View more earnings on ADepending on the particular phase of a business cycle, some industries will perform better than others.Compared to the aggregate P/E ratio of the 84.08 in the Diagnostics & Research industry, Agilent Technologies Inc. has a lower P/E ratio of 44.68. Shareholders might be inclined to think that they might perform worse than its industry peers. It's also possible that the stock is undervalued.Price to earnings ratio is not always a great indicator of the company's performance. Depending on the earnings makeup of a company, investors may not be able to attain key insights from trailing earnings.See more from Benzinga * Agilent's Debt Overview * Earnings Scheduled For August 18, 2020 * Stocks That Hit 52-Week Highs On Monday(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
- 08/19/2020
|
Agilent's (A) Q3 Earnings Beat Estimates, Revenues Down Y/Y
- Agilent Technologies' (A) fiscal third quarter results reflect growth in pharmaceutical and food market. However, COVID-19 headwinds were concerns.
- 08/19/2020
|
Stocks making the biggest moves in the premarket: Target, Lowe's, J&J, Momenta, Gilead & more
- The stocks making the biggest moves in premarket trading include Target, Lowe's, J&J, Momenta, Gilead, and more.
- 08/19/2020
|
Agilent Falls In Pre-Market As Quarterly Sales Miss; Oppenheimer Says Hold
- Shares in Agilent Technologies (A) are down in pre-market trading after third-quarter sales missed analysts’ expectations and the company said it exited July with modest growth across all major markets.The stock is declining 2.1% to $95.80 in Wednesday’s pre-market session. Agilent’s (A) third-quarter sales fell 1% to $1.26 billion and is below the $1.21 billion estimated by analysts. On an adjusted basis and excluding items, Agilent reported earnings of $243 million or $0.78 per share for the three months ended July 31. Analysts had expected the company to earn $0.66 per share.Agilent, an equipment maker which serves the life sciences, diagnostics and applied chemical markets, said that although it sees a gradual improvement in lab access for its customers and increased non-COVID-19 testing volumes, it is still not at pre-COVID-19 levels.“Under challenging conditions created by the global COVID-19 pandemic, Agilent again delivered strong results,” said Agilent CEO Mike McMullen. “While the world’s economies are expected to recover at different rates in the fourth quarter, we remain focused on growth and investing for the future, while effectively managing expenses.”Separately, Agilent announced that it will invest $150 million to expand it Colorado production facility and add manufacturing lines to more than double the current capacity for manufacturing therapeutic oligos. Oligos, which are short DNA and RNA molecules used to create nucleic acid-based therapeutics, hold the potential to be used in developing treatments for cancer, COVID-19, cardiovascular disease, rare and infectious diseases, and other conditions.The expansion plans come as Agilent expects the supplier market for therapeutic oligos to exceed $750 million in 2025 with projected double-digit annual growth over the next five years.Agilent shares have recovered after hitting a low in March and are now up 15% on a year-to-date basis. (See Agilent stock analysis on TipRanks)Meanwhile, Needham analyst Stephen Unger maintained a Hold rating following the quarterly results, saying that at the price of $97.86, A shares are trading at 27.6x the EPS estimate of $3.54 for the 12-month period ending Aug. 2021, which is within his revised target trading range of 24.0-30.0x.“Given increased upside potential with the ongoing recovery from COVID-19, we consider the upper half of the range to be fair value (share price of $96.00-$106.00),” Unger wrote in a note to investors.Overall, Wall Street analysts are cautiously optimistic on the stock. The Moderate Buy consensus is split between 6 Hold and 5 Buys. Meanwhile, the $93.78 average analyst price target indicates downside potential of 4.2% over the coming 12 months.Related News: Walmart Delivers Earnings Triumph; E-Commerce Sales Double Home Depot Sales Exceed Estimates As Shoppers Pile On DIY Products Kohl’s Dips 17% As Covid-19 To Hit Back-to-School Sales More recent articles from Smarter Analyst: * GFL Environment Rebukes Spruce Point’s Debt Claims; Shares Rise * KBR To Buy Space Contractor Centauri For $800M; Shares Pop 6% * Blackstone Set To Win Bid For Takeda’s Consumer Health Unit - Report * Lowe’s Delivers Blowout Q2 As Online Sales Surge 135%
- 08/19/2020
|
Wall Street Breakfast: S&P 500 To Take Aim At New Record
- Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify.
- 08/19/2020
|
Agilent Technologies Inc (A) Q3 2020 Earnings Call Transcript
- A earnings call for the period ending July 31, 2020.
- 08/19/2020
|
Agilent Technologies Inc. (A) Q3 2020 Earnings Call Transcript | AlphaStreet
- Final earnings conference call transcript of Agilent Technologies Inc. - A stock
- 08/19/2020
|
Agilent Technologies Inc. (A) CEO Mike McMullen on Q3 2020 Results - Earnings Call Transcript
- Agilent Technologies Inc. (NYSE:A) Q3 2020 Results Conference Call August 18, 2020 04:30 PM ET Company Participants Ankur Dhingra - VP, IR Mike McMullen - President and CEO Bob McMahon - SVP and CFO Jacob Thaysen - President, Life Sciences & Applied Markets Group Sam Raha - President, Diagnostics and Genomics Group Padraig McDonnell - President, Agilent CrossLab Group Conference Call Participants Doug Schenkel - Cowen Vijay Kumar - Evercore ISI Tycho Peterson - JP Morgan Puneet Souda - Leerink Derik de Bruin - Bank of America Brandon Couillard - Jefferies Dan Leonard - Wells Fargo Catherine Schulte - Baird Steve Willoughby - Cleveland Research Dan Brennan - UBS Patrick Donnelly - Citigroup Jack Meehan - Nephron Research Presentation Operator Good afternoon, and welcome to the Agilent Technologies Third Quarter Earnings Conference Call.
- 08/18/2020
|
Agilent Technologies (A) Beats Q3 Earnings and Revenue Estimates
- Agilent (A) delivered earnings and revenue surprises of 18.18% and 3.90%, respectively, for the quarter ended July 2020. Do the numbers hold clues to what lies ahead for the stock?
- 08/18/2020
|
Agilent Technologies shares dip 2% on decline in revenue
- Agilent Technologies Inc. shares were down 2% in after-hours trading Tuesday after the research, development, and manufacturing company reported fiscal third-quarter results that were roughly in line with Wall Street estimates for earnings but missed on revenue. Agilent reported net income of $199 million, or 64 cents a share, compared with net income of $191 million, or 61 cents a share, in the year-ago quarter. Revenue declined 1% to $1.26 billion from $1.27 billion a year ago. Analysts surveyed by FactSet had expected earnings of 66 cents a share on revenue of $1.21 billion. Agilent shares are up about 15% this year. The broader S&P 500 index has improved nearly 5% in 2020.
- 08/18/2020
|
Agilent Reports Third-Quarter Fiscal Year 2020 Financial Results
- Agilent announces third quarter fiscal year 2020 financial results.
- 08/18/2020
|
Charting a pulling-teeth breakout attempt: S&P 500, Nasdaq challenge record territory
- Technically speaking, the S&P 500 and Nasdaq Composite have registered nominal record highs this week, though a pulling-teeth breakout attempt remains...
- 08/18/2020
|
Agilent's Debt Overview
- Shares of Agilent Technologies Inc. (NYSE: A) rose by 14.74% in the past three months. Before having a look at the importance of debt, let's look at how much debt Agilent Technologies has.Agilent Technologies's Debt Based on Agilent Technologies's financial statement as of June 1, 2020, long-term debt is at $1.79 billion and current debt is at $700.00 million, amounting to $2.49 billion in total debt. Adjusted for $1.32 billion in cash-equivalents, the company's net debt is at $1.16 billion.Investors look at the debt-ratio to understand how much financial leverage a company has. Agilent Technologies has $9.46 billion in total assets, therefore making the debt-ratio 0.26. As a rule of thumb, a debt-ratio more than 1 indicates that a considerable portion of debt is funded by assets. A higher debt-ratio can also imply that the company might be putting itself at risk for default, if interest rates were to increase. However, debt-ratios vary widely across different industries. A debt ratio of 35% might be higher for one industry, whereas average for another.Why Debt Is Important Besides equity, debt is an important factor in the capital structure of a company, and contributes to its growth. Due to its lower financing cost compared to equity, it becomes an attractive option for executives trying to raise capital.Interest-payment obligations can impact the cash-flow of the company. Having financial leverage also allows companies to use additional capital for business operations, allowing equity owners to retain excess profit, generated by the debt capital.See more from Benzinga * Earnings Scheduled For August 18, 2020 * Stocks That Hit 52-Week Highs On Monday * Stocks That Hit 52-Week Highs On Thursday(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
- 08/18/2020
|
Agilent to Expand State-of-the-Art Manufacturing Capacity for Nucleic Acid-Based Therapeutics
- Agilent to expand state-of-the-art manufacturing capacity for nucleic acid-based therapeutics.
- 08/18/2020
|
A Peek Into The Markets: US Stock Futures Edge Higher Ahead Of Walmart Earnings
- Pre-open movers
U.S. stock futures traded slightly higher in early pre-market trade, as investors are awaiting earnings from Walmart Inc (NYSE: WMT), Advance Auto Parts, Inc. (...
- 08/18/2020
|
Bill Ackman Bows Out of Berkshire, Blackstone and Park Hotels & Resorts
- Guru releases 2nd-quarter portfolio Continue reading...
- 08/17/2020
|
MOBILion Closes $35M Series B Financing Round
- MOBILion Systems, Inc., a pioneer in fast, efficient, high- resolution instrumentation for biomarker discovery, diagnostics and therapeutic development, today announced a $35 million Series B funding round. The oversubscribed round was led by aMoon, with the remaining funds contributed by existing investors, including Agilent Technologies (NYSE: A), IP Group, Hostplus and Cultivation Capital.
- 08/17/2020
|
Not Your Father’s Tesla
- PREVIEW When it comes to electric-vehicle announcements, investors have gotten used to alluring and fast cars. (TSLA)’s top Model S sedan can go from zero to 60 miles per hour in 2.3 seconds. But the electric-vehicle revolution is going to come in all shapes, sizes, and speeds.
- 08/15/2020
|
The Zacks Analyst Blog Highlights: JD, Agilent, Nordson, Deere and Dollar General
- The Zacks Analyst Blog Highlights: JD, Agilent, Nordson, Deere and Dollar General
- 08/13/2020
|
Agilent (A) Gears Up for Q3 Earnings: What's in the Cards?
- Agilent's (A) leadership position and strength in revenue segments are likely to reflect on fiscal third-quarter results. However, the global coronavirus-driven economic crisis may have been a woe.
- 08/12/2020
|
What Is The Ownership Structure Like For Agilent Technologies, Inc. (NYSE:A)?
- Every investor in Agilent Technologies, Inc. (NYSE:A) should be aware of the most powerful shareholder groups. Large...
- 08/12/2020
|
At US$96.30, Is Agilent Technologies, Inc. (NYSE:A) Worth Looking At Closely?
- Agilent Technologies, Inc. (NYSE:A) saw a significant share price rise of over 20% in the past couple of months on the...
- 08/12/2020
|
Charting the approach of record highs, S&P 500 rises amid market rotation
- Technically speaking, the U.S. benchmarks’ already-bullish backdrop has strengthened amid rotational August price action, writes Michael Ashbaugh.
- 08/11/2020
|
Agilent Technologies (A) Expected to Beat Earnings Estimates: Should You Buy?
- Agilent (A) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 08/11/2020
|
Agilent Technologies (A) to Release Quarterly Earnings on Tuesday
- Agilent Technologies (NYSE:A) will post its quarterly earnings results after the market closes on Tuesday, August 18th. Analysts expect Agilent Technologies to post earnings of $0.66 per share for the quarter. Investors that are interested in registering for the company’s conference call can do so using this link. Agilent Technologies (NYSE:A) last posted its earnings […]
- 08/11/2020
|
COVID-19 Impacts: Graphite Electrode Market Will Accelerate at a CAGR of Almost 2% Through 2020-2024 | Increased Demand for High-quality Steel to Boost Growth | Technavio
- The Global Graphite Electrode Market will grow by 182.85 th MT during 2020-2024
- 08/11/2020
|
Laboratory Analytical Instruments and Consumables Market Analysis Highlights the Impact of COVID-19 (2020-2024) | Rising Applications of Analytical Instruments to Boost Market Growth | Technavio
- The Global Laboratory Analytical Instruments and Consumables Market will grow by USD 13.81 bn during 2020-2024
- 08/10/2020
|
Brenntag AG (BNTGF) CEO Christian Kohlpaintne on Q2 2020 Results - Earnings Call Transcript
- Brenntag AG. (OTCPK:BNTGF) Q2 2020 Earnings Conference Call August 06, 2020, 08:00 AM ET Company Participants Christian Kohlpaintne - Chief Executive Officer Georg Müller - Chief Financial Officer Conference Call Participants Rory McKenzie - UBS Laurent Favre - Exane BNP Paribas Rajesh Kumar - HSBC Markus Mayer - Baader Helvea Steven Goulden - Deutsche Bank Isha Sharma - MainFirst Bank Chetan Udeshi - JPMorgan.
- 08/09/2020
|
COVID-19 Impacts: PCR System for Food Diagnostics Market will Accelerate at a CAGR of over 8% through 2020-2024 | Rising Foodborne Illnesses to Boost Growth | Technavio
|
Automated Test Equipment Market Highlights the Impact of COVID-19 2020-2024 | Augmented Production of Electronic Goods to Boost Market Growth | Technavio
|
Automated Test Equipment Market Highlights the Impact of COVID-19 2020-2024 | Augmented Production of Electronic Goods to Boost Market Growth | Technavio
- The Global Automated Test Equipment Market will grow by USD 1.47 bn during 2020-2024
- 08/08/2020
|
Here's Why Momentum Investors Will Love Agilent Technologies (A)
- Does Agilent Technologies (A) have what it takes to be a top stock pick for momentum investors? Let's find out.
- 08/07/2020
|
HighRadius Adds New Leader to Drive Finance Digital Transformation in Growing Enterprise Client Base
- HighRadius, a fintech enterprise Software-as-a-Service (SaaS) company specializing in automating the order-to-cash and treasury management processes,
- 08/07/2020
|
Penn State Microbiome Center and GALT Enter Collaboration to Advance Research
- Researchers will utilize GALT's Prospector high-throughput microbial isolation and cultivation system to generate banks of live microbial isolates.
- 08/06/2020
|
Analysis on Impact of COVID-19- Global Explosive Detection Equipment Market 2020-2024 | Evolving Opportunities with Agilent Technologies Inc. and Bruker Corp. | Technavio
- The Global Explosive Detection Equipment Market will grow by $2.72 bn during 2020-2024
- 08/05/2020
|
Agilent Technologies At Upper End Of Buy Range With Earnings Due
- To build your earnings season watch list, look for stocks in or near a potential buy range ahead of their next report. One company that fits that bill is Agilent Technologies (A). It's expected to report on Aug. 18. The stock is approximately 5% above a 93.14 buy point from a first-stage flat base. Buying a stock just ahead of...
- 08/04/2020
|
STERIS plc (STE) CEO Walter Rosebrough on Q1 2021 Results - Earnings Call Transcript
- STERIS plc (NYSE:STE) Q1 2021 Results Conference Call August 03, 2020 10:00 AM ET Company Participants Julie Winter - Investor Relations Walter Rosebrough - President and Chief Executive Officer Michael Tokich - Senior Vice President and Chief Financial Officer Daniel Carestio - Senior Vice President and Chief Operating Officer Conference Call Participants David Turkaly - JMP Securities Christopher Cooley - Stephens Inc Michael Matson - Needham and Company Lawrence Keusch - Raymond James Matthew Mishan - KeyBanc Capital Markets Presentation Operator Good day, and welcome to the STERIS PLC First Quarter Fiscal 2021 Conference Call and Webcast.
- 08/04/2020
|
Charting a solid August start: S&P 500, Nasdaq stage latest summer breakouts
- Technically speaking, the U.S. benchmarks’ bigger-picture backdrop remains bullish amid a solid August start, writes Michael Ashbaugh.
- 08/04/2020
|
Analysts Anticipate Agilent Technologies Inc (NYSE:A) Will Post Earnings of $0.54 Per Share
- Analysts predict that Agilent Technologies Inc (NYSE:A) will report earnings of $0.54 per share for the current quarter, according to Zacks. Five analysts have made estimates for Agilent Technologies’ earnings, with the lowest EPS estimate coming in at $0.37 and the highest estimate coming in at $0.70. Agilent Technologies reported earnings per share of $0.76 […]
- 08/04/2020
|
COVID-19 Impacts: Biotechnology Reagents Market Will Accelerate at a CAGR of about 8% through 2020-2024|Presence of High-Throughput and Novel Technologies to Boost Growth| Technavio
- The Global Biotechnology Reagents Market will grow by USD 37.87 bn during 2020-2024
- 08/04/2020
|
Samyang Biopharm USA Announces Hyun Jung Helen Lee, M.D., Named to PharmaVOICE 100
- Samyang Biopharm USA, Inc. (https://us.samyangbiopharm.com) a global biotech subsidiary of the Samyang Biopharmaceuticals Corp. (https://samyangbiopha
- 08/03/2020
|
Craving Healthcare: A Beginner's Guide And My 7 Picks
- The Healthcare sector has significantly outperformed the S&P 500 in the last decade and with lower volatility – the only sector to do so.
- 07/31/2020
|
These ‘green’ stocks would thrive under a Biden administration, according to fund managers
- ‘Energy transformation will happen with or without politicians,’ says Jonathan Waghorn of the Guinness Atkinson Alternative Energy Fund.
- 07/29/2020
|
Tractor Supply, Tanger Factory, Cisco, Agilent and Benefitfocus as Zacks Bull and Bear of the Day
- Tractor Supply, Tanger Factory, Cisco, Agilent and Benefitfocus as Zacks Bull and Bear of the Day
- 07/29/2020
|
Charting a (bullish) holding pattern, S&P 500 digests break to 5-month highs
- The major U.S. benchmarks are acting well technically, though amid increasingly sideways late-July price action, writes Michael Ashbaugh.
- 07/28/2020
|
Ecolab : Second Quarter Reported Diluted Continuing Operations EPS $0.44; Adjusted Diluted Continuing Operations EPS $0.65, -49% | MarketScreener
|
Agilent to Webcast Third-Quarter Fiscal Year 2020 Financial Results Conference Call
- Agilent to webcast third-quarter financial results conference call August 18.
- 07/27/2020
|
